CarbonMeta Technologies, Inc. - Annual Report: 2013 (Form 10-K)

a92714010k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10- K

þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE

ACT OF 1934

FOR THE TRANSITION PERIOD FROM ________________ TO _________________

COMMISSION FILE NUMBER: 000-33231

	COROWARE, INC.
	(EXACT NAME OF THE COMPANY AS SPECIFIED IN ITS CHARTER)

Delaware		95-4868120
(State or Other Jurisdiction		(I.R.S. Employer
of Incorporation)		Identification No.)

601 108th Avenue Northeast, Suite 1900

Bellevue, WA 98004

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

(800) 641-2676

(ISSUER REGISTRANT TELEPHONE NUMBER)

SECURITIES REGISTERED UNDER SECTION 12(B) OF THE ACT: NONE

SECURITIES REGISTERED UNDER SECTION 12(G) OF THE ACT:

COMMON STOCK, PAR VALUE $0.0001

(TITLE OF CLASS)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) the Act. Yes o No þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. o Yes þ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). o Yes þ No

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained in this form, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer (Do not check if a smaller reporting company)	o	Smaller reporting company	þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No þ

The aggregate market value of the of the registrant’s common stock held by non-affiliates of the registrant, computed by reference to price at which the common equity was sold, or the average bid and asked price of such common stock as of September 30, 2014, was $0.0001. For purposes of this computation, the registrant has excluded the market value of all shares of its common stock reported as being beneficially owned by executive officers and directors and holders of more than 10% of the common stock on a fully diluted basis of the registrant; such exclusion shall not, however, be deemed to constitute an admission that any such person is an “affiliate” of the registrant.

Number of shares of common stock ($0.0001 par value) outstanding as of November 21, 2014: 8,414,279,084 shares.

INDEX

	PART I

Item 1.	Business.	1
Item 1A.	Risk factors	6
Item 1B.	Unresolved Staff Comments	6
Item 2.	Properties.	6
Item 3.	Legal Proceedings.	6
Item 4.	Mine Safety Disclosures.	6

	PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Registrant Purchases of Equity Securities.	6
Item 6.	Selected Financial Data	9
Item 7.	Management’s Discussion and Analysis or Financial Condition and Results of Operations	9
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	17
Item 8.	Financial Statements.	17
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.	17
Item 9A.	Controls and Procedures.	17
Item 9B.	Other Information.	18

	PART III

Item 10.	Directors, Executive Officers, and Corporate Governance.	19
Item 11.	Executive Compensation.	20
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.	23
Item 13.	Certain Relationships and Related Transactions, and Director Independence.	24
Item 14.	Principal Accounting Fees and Services	25

	PART IV

Item 15.	Exhibits.	27
SIGNATURES		35

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

In this annual report, references to “CoroWare,” “the Company,” “we,” “us,” and “our” refer to CoroWare, Inc.

This Annual Report on Form 10-K contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this Annual Report on Form 10-K. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this Annual Report on Form 10-K reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading "Risks Related to Our Business" below, as well as those discussed elsewhere in this Annual Report on Form 10-K. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K.

CoroWare undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Annual Report on Form 10-K, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout this Annual Report, which are designed to advise interested parties of the risk factors that may affect our business, financial condition, results of operations and prospects.

PART I

ITEM 1. BUSINESS

Overview

CoroWare, Inc is a public holding company whose principal subsidiary, CoroWare Technologies, Inc. (“CTI”), has expertise in information technology consulting, mobile robotics, and affordable collaboration. Through our subsidiary, CoroWare delivers custom engineering services, hardware and software products, and subscription services that benefit customers in North America, Europe, Australia, Asia and the Middle East. Our customers span multiple industry sectors and comprise universities, large enterprises and small businesses, software and hardware product development companies, and non-profit organizations.

Employees

As of December 31, 2013, we had eighteen (18) employees composed of one (1) full-time Officer and CEO, one (1) full-time Director of Sales, one (1) full-time Finance Administrator, two (2) full-time Business Unit Managers, eleven (11) full-time engineers, and two (2) part-time engineers. Our employees are not represented by a union. We consider relations with our employees to be positive and productive.

COROWARE TECHNOLOGIES, INC.

CTI is a software professional services company with a strong focus on information technology integration and robotics integration, business automation solutions, and unmanned systems solutions to its customers in North America and Europe.

CTI’s expertise includes the deployment and integration of computing platforms and applications, as well as the development of unmanned vehicle software and solutions for customers in the research, commercial, and homeland security market segments. CTI shall continue to offer its high value software systems development and integration services that complement the growing trend in outsourced software development services in Asia, Latin America, and Eastern Europe.

CoroWare Technologies comprises three separately managed lines of business:

	●	CoroWare Business Solutions: IT and lab management; business intelligence; software architecture, design and development; content delivery; partner and program management.
	●	Robotics and Automation: Custom engineering such as visualization, simulation and software development; and mobile robot platforms.
	●	Enhanced Collaboration Solution: Collaboration and conferencing products, solutions and subscription services.

The Company’s revenues are principally derived from standing contracts that include Microsoft (partner management and IT professional services), a European auto manufacturer (simulation software custom development), and other customers whose product development groups require custom software development and consulting companies. Existing contract revenues vary month by month based on the demands of the clients. The Company’s collaboration effort is in the early stages of growth and will require additional working capital to compete effectively against new entrants in this rapidly growing market.

CoroWare Business Solutions

CoroWare Business Solutions (CBS) offers products, solutions, and IT consulting services that help our customers deliver high quality products, solutions and services.

Products and Solutions

In 2010, we announced two new products for the cloud service providers and enterprise customers:

	●	CoroWare Usage Reporter for Vidyo, a software package that provides usage statistics for Vidyo brand high-definition video conferencing systems.
	●	Billing Integration Framework™ for MetraTech and Vidyo, a software solution that integrates dynamic usage- and subscription-based billing from MetraTech Corp and high definition videoconferencing systems from Vidyo.

In early 2012, we announced CoroWare License Manager™, a software license management solution that offers Cloud Service Providers and on-premises software publishers the ability to remotely enable, monitor, and configure cloud-based applications using a centralized management server.

In 2012, we announced Billing Integration Framework for Accumulus and Vidyo, a software solution that integrates flexible billing from Accumulus Corp with the call detail records from Vidyo to create more flexible video conferencing subscription services.

Business Intelligence

Our CTI’s solutions development group has created a variety of business intelligence applications to enable our customers to better understand and manage the data surrounding their own products and business services.

Release Management

Our program managers are experts in Microsoft's product and solution development tools and processes. CTI uses that experience to create product specifications, develop project plans, and perform security and release management audits – with the objective of helping Microsoft deliver its solutions and products efficiently, affordably and on schedule.

Lab Management

CTI's team of experienced hardware and software deployment engineers architect, deploy and support state-of-the-art computer lab facilities that include the latest builds of operating systems, developer tools, and servers. CTI employees currently provide lab management and systems engineering support services in three Microsoft data centers and labs.

Software Development

CTI’s solutions development group has been instrumental in helping product development companies, including MetraTech, design, prototype, develop and test new products and solutions. CoroWare’s consulting staff comprises a wide range of software architects with over 20 years’ experience, “user experience” application developers, web service software developers, database consultants, and project managers.

In order to compete with outsourcing software and IT consulting companies in India and China, CoroWare established a near shore consulting services group in 2007 as a low cost alternative with same time zone presence. CoroWare's Latin America partnerships offer superior cost dynamics and a near time zone alternative to Europe / US businesses requiring Spanish language capability. CoroWare's Near Shore Consulting Services offer a stable rate against the dollar, as well as close proximity, and a familiarity with US business processes.

Robotics and Automation (R&A)

We are a mobile robotics solutions integrator in the research community and have expertise in robotics simulation and software development. Our CoroBot and Explorer product lines are being used by over 50 corporate and academic researchers today.

Custom Engineering

We offer custom engineering expertise to customers who are looking for product realization, robotics simulation, systems architecture and design, and robotic applications development services. We believe CTI is uniquely positioned with its knowledge of robotics simulation; Player-Stage and Robotic Operating System (ROS) running on Ubuntu Linux systems; Concurrency and Coordination Runtime (CCR) and Decentralized Software Services (DSS) running on Microsoft Windows systems; embedded systems software development; and hardware and software integration services to help its customers deliver innovative product and solutions.

Solutions and Products

In May 2007, we began shipping the CoroBot Classic, an affordable and flexible mobile robot that was designed to minimize the complexity of robotic development. Combining a powerful PC-class platform with a robust, object-oriented software development system empowers researchers and robotics application developers to rapidly deploy and develop robotic solutions. Some university customers are deploying CoroBot Classics for use in various lab activities, including the development of swarm robotics applications designed to leverage groups of robots to complete complex tasks.

In June 2009, we began shipping the CoroBot Explorer. With more powerful motors, larger payload capacity, articulated suspension and enclosed electronics it is suitable for indoor or outdoor usage.

In 2010 and early 2012, we announced new features for the CoroBot Explorer II platform and support for Robot Operating System, which we believe will improve our sales into the research and education market segments.

In 2012, we reorganized our robotics division and moved the facility to Charlotte, North Carolina, to take better advantage of strategic partnerships with the University of North Carolina Charlotte.

In February 2013 we released the CoroBot Junior as a new lower cost research unmanned ground vehicle. In September 2013, we released the CoroBot Pro, a much more powerful unmanned ground vehicle. In November 2013, the High Capacity Robotic Arm was released, providing both a long reach and large payload.

Enterprise Collaboration Solutions (ECS)

Vidyo Reseller Business

In early 2009, we launched our collaboration – now referred to as Enterprise Collaboration Solutions - initiative in order to address the needs of enterprise customers with distributed business operations that are turning to new technologies to address the cost of doing business in a world that is increasingly dependent on suppliers, partners and customers worldwide. In order to overcome these challenges, enterprise customers are looking for solutions that are demonstrably effective and operationally affordable. As a result, small, medium and large sized businesses, including consulting companies, non-profit groups, and distance learning companies, are all giving serious consideration to purchasing affordable high definition videoconferencing solutions.

Through our partnership with Vidyo (http://www.vidyo.com), we are deploying high definition video conferencing solutions, including collaboration room systems, and offering CoroCall TM Business Class HD Video Conferencing (http://www.corocall.com), an affordable high definition videoconferencing subscription service that is based on Vidyo’s technology.

CoroCall Subscription Services

As CoroWare began selling the Vidyo product line in 2009, many customers expressed a desire to mitigate capital expenditures and purchase cloud-based communication services instead. In response to this customer demand, CoroWare announced its CoroCall Business Class HD Video Conferencing subscription service in 2009, and subsequently upgraded to support improved audio and video conferencing capabilities which are superior to many of our competitors today.

In 2012, we expanded the CoroCall Business Class HD Video Conferencing service with the addition of integrated call recording and webcast. In addition, we also enhanced the security of the offering by implementing 128 bit AES encryption. In 2012, we also became a reseller of VidyoCast, a broadcast service that incorporates Vidyo’s network tolerant video streaming into the broadcast arena.

Although this business is still in its early stages of growth, we have won and are pursuing significant customer opportunities with financial consulting organizations, product development/sales companies, religious organizations, and employment recruiters. This also expands the options available to customers of the video conferencing service, providing custom dial in phone numbers.

In 2013, we solidified a presence in the area of tele-health with a focus on providing HIPAA compliant video conferencing, particularly for mental tele-health facilities.

CoroCall Product Line

In 2010, we announced our first enhanced collaboration product, CoroWare NameTag, a Windows-based application that lets desktop video conferencing users customize their webcam experience. We have had significant corporate adoption of NameTag.

In early 2012, we expanded our range of products when the Company announced the early adopter release of CoroCall Communications, an Internet telephony, conferencing, and communications system. CoroCall Communications is a standalone appliance server with features that were previously available only to large enterprises at a much higher price, offering customers an integrated Internet telephony solution that includes phone communications, high definition (HD) audio and video conferencing, and advanced call management. 2102 and the beginning of 2013 have brought several enhancements and additions to our CoroCall service. Recording and streaming capabilities were added to the platform allowing users to record and or stream video conferences on the fly without administrative intervention or support. Additionally our service is now deployed in a secure manner utilizing HTTPS and AES encryption, insuring that our customers’ calls and data are secure from hackers and potential eavesdroppers of sensitive information. By providing these new capabilities and managing customized solutions with API management, we have developed customers in vertical markets to include Health care, Education and legal applications. Law firms are utilizing our platforms for remote depositions and more. Schools are conducting virtual field trips and extended care facilities are connecting patients with care providers via our CoroCall Videoconferencing platform.

We have expanded our distribution model by developing a network of Value Added Service Providers (VASP’s). By adding CoroCall cloud based subscription services to their existing telephony, data management and other telecom services, there resellers are developing new recurring revenue streams without having to build out infrastructure to do so.

Competition

Competitors in the IT consulting market comprise a combination of large and well established companies, such as Avanade and Tata Consultancy Services; and smaller, privately held consulting companies with practices in a single vertical arena such as custom software development, telecom billing, multimedia production and many other vertical industries.

We have maintained long-term relationships and have been successful in renewing contracts and in signing multi-month or yearlong contracts with key customers - including Microsoft and MetraTech, and are building similar client relationships with new customers.

Competitors in the mobile robotics and custom engineering marketplaces have comprised iRobot (IRBT), Adept / MobileRobots (ADEP), and privately held companies such as K-Team Mobile Robotics, RoboSoft, and Evolution Robotics. New entrants in this marketplace include Aethon, neato robotics, Brock Technologies, and Contineo Robotics.

Competitors in the collaboration market include:

	●	Legacy videoconferencing vendors such as Polycom, Tandberg/Cisco and Lifesize/Logitech
	●	Legacy videoconferencing service providers, such as AT&T, that deploy and support legacy equipment from Polycom, Tandberg/Cisco and Lifesize/Logitech
	●	New entrants in affordable and modest quality videoconferencing services, such as oovoo and Nefsis
	●	New entrants into cloud based bridging and multipoint services such as Blue Jeans, Vidtel and others
	●	Upgrades to existing Data conferencing platforms to include multi party video within the collaboration tool. i.e. Go to Meeting, Webex.

Customers

All three divisions saw growth in their customer bases in 2013 as compared with 2012. CBS added additional contracts with existing customers and added additional large enterprise accounts as well. R&A engaged with a number of additional universities and research facilities. ECS added customers to its hosted solutions and additional resellers, as well as securing product and accessory sales to a number of customers.

ARiCON Joint Venture

CoroWare, Inc. (“Company”) entered into a joint venture agreement (“Joint Venture Agreement”) with Lucas Snyder (“Snyder”) as of September 24, 2012, whereby the parties have formed a North Carolina limited liability company, ARiCON, LLC, to implement a joint venture that will develop and market mobile robot platforms, applications, and solutions for the construction industry.

The Company will contribute mobile robotics development capabilities and certain equipment to the joint venture; and Snyder will contribute his construction industry knowledge, expertise and customer relationships.

Pursuant to the Joint Venture Agreement, on September 27, 2012, the Company contributed $10,000 cash and 38,000,000 shares of its common stock to ARiCON, LLC, at a price of $0.001 per share in a private placement exempt from registration under the Securities Act of 1933 in reliance on Section 4(2) of the Securities Act. The aggregate proceeds of the contribution into the formation of the joint venture were valued at $59,400.

Regulation

Our services and products are not uniquely subject to governmental or industry regulations.

Research & Development

Our research and development activities have primarily been focused on the development of software components, mobile robot platforms such as the CoroBot Explorer and CoroCall Business Class HD Video Conferencing. We intend to continue developing hardware and software products that we believe will potentially grow CoroWare's collaboration and mobile robotics products, solutions and services.

Research and development expenses from continuing operations for the years ended December 31, 2013 and 2012 were $23,415 and $58,948, respectively.

Products

CoroBot Classic:

CoroBot Classic was created to minimize the complexity of robot development. By combining a powerful PC-class platform with a robust, object-oriented software development system, the CoroBot Classic empowers users to rapidly deploy and develop robotic solutions. The CoroBot Classic also assists the hardware developer with additional physical mounting space, ports, sensors and communication devices.

CoroBot Explorer:

Our CoroBot Explorer mobile robot was created to expand on the capabilities of the CoroBot Classic and deliver a rugged indoor/outdoor platform that can withstand environmental elements such as dirt, dust, leaf debris, sand, gravel and shallow puddles. Extra ports and surface mounting space make Explorer a robust and expandable research robot.

CoroBot Junior:

Our CoroBot Junior mobile robot is an affordable smart UGV that includes a water resistant chassis with an integrated PC-class CPU, on-board infrared sensors, an HD 1080p camera, and a wireless controller for teleoperation. The CoroBot Junior is available with two chassis options: 3 wheeled (2 drive motor) chassis and 4 wheel (4 drive motor) chassis.

CoroBot Pro:

Our CoroBot Pro mobile robot is the most powerful member of the CoroBot family of smart unmanned ground vehicles (Smart UGV) and robotics development platforms for researchers and educators. The CoroBot Pro expands CoroWare’s affordable and flexible robotics product line by offering a more powerful Intel i7 processor and supporting a wider range of sensor options, including the Point Grey Bumblebee® stereo vision camera, Microsoft Kinect sensor, and a wide variety of high definition webcams.

Usage Reporter for Vidyo:

Our Usage Reporter for Vidyo is a Windows-based software package that analyzes detailed video conferencing call records, including the number of Vidyo rooms, ports, users, and conference call minutes. This software product is an affordable and effective way for customers to generate video conferencing usage statistics that can be used to distribute costs and make informed purchasing decisions.

ITEM 1A. RISK FACTORS

As a smaller reporting company, as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we are not required to provide the information required by this item.

ITEM 1B. UNRESOLVED STAFF COMMENTS

ITEM 2. PROPERTIES

Corporate Headquarters

On August 1, 2011, the Company entered into a lease agreement on corporate offices located at 1410 Market Street, Kirkland, WA which terminated on December 23, 2013. Under this lease, the Company was obligated to pay an average monthly rent of $4,088 in 2012 and $4,233 in 2013. Since the termination of this lease, the Company is entered into a monthly lease agreement at a cost of $1,038.

Our corporate headquarters is located at 601 108th Avenue Northeast, Suite 1900, Bellevue, WA 98004.

Robotics Division

On January 1, 2013, the Company entered into a lease agreement on corporate offices located at 8701 Mallard Creed Rd., Charlotte, NC which terminated on December 31, 2013. Under this lease, the Company was obligated to pay monthly rent of $2,000 in 2013. As of August 14, 2013, the Company terminated this lease with no further obligations in order to sign a new lease at 1064 Van Buren Avenue, Indian Trail, NC. This lease continues through August 31, 2014 at a monthly cost of $1,247 per month. The Company signed a new lease as of April 1, 2014 through March 31, 2016 at an average monthly cost of $1,300 in 2014, $1,317 in 2015 and $1,350 in 2016.

ITEM 3. LEGAL PROCEEDINGS

CoroWare is not currently a party to, nor is any of our property currently the subject of, any pending legal proceeding that will have a material adverse effect on our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Prices of Common Stock

Beginning in February 2002, CoroWare’s common stock was eligible for listing in the OTC Bulletin Board. Our trading symbol was “SRMW” until such time as our acquisition of Hy-Tech Technology Group, Inc. on January 31, 2003 when our symbol became “HYTT”. In November 2006, our name was changed to Innova Robotics & Automation, Inc. and the trading symbol was changed to INRA. In April 2008, we became CoroWare, Inc. and our trading symbol was changed to CROE. In April 2009, in conjunction with a 1-for-300 reverse stock split, our trading symbol was changed to COWI. In January 2012, we revised the par value of our Common Stock from $0.001 to $0.0001. In July 2012, we effected a reverse split of 1-for-200. In January 2014, we effected a reverse split of 1-for-200.

Our common stock is quoted on the OTCQB exchange under the symbol, “COWI”. Accordingly, there can be no assurance as to the liquidity of any markets that may develop for our common stock, the ability of holders of our common stock to sell our common stock, or the prices at which holders may be able to sell our common stock.

The following table sets forth the quarterly high and low sales prices as reported during the last two fiscal years ended December 31, 2013 and December 31, 2012.

COMMON STOCK

Year Ended December 31, 2013	High		Low
First Quarter	$	0.84	$	0.02
Second Quarter	$	0.04	$	0.02
Third Quarter*	$	0.02	$	0.02
Fourth Quarter	$	0.02	$	0.02

Year Ended December 31, 2012	High		Low
First Quarter	$	8.00	$	4.00
Second Quarter	$	4.00	$	4.00
Third Quarter*	$	4.00	$	0.20
Fourth Quarter	$	0.60	$	0.04

These quotations represent interdealer prices, without retail markup, markdown, or commission, and may not reflect actual transactions. As of January 29, 2014, there were approximately 230 record holders of the Company's common stock. This reflects a reverse 200 for 1 reverse split of the stock on July 6, 2012 and on January 6, 2014.

Dividend Policy

The Company has never declared or paid any cash dividends on its common stock. The Company anticipates that any earnings will be retained for development and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future. Additionally, as of December 31, 2013 and 2012 the Company has issued and has outstanding shares of Series B Preferred Stock which are entitled, prior to the declaration of any dividends on common stock, to earn a 5 percent dividend, payable in either cash or common stock of the Company. The Board of Directors has sole discretion to declare dividends based on the Company's financial condition, results of operations, capital requirements, contractual obligations and other relevant factors. At December 31, 2013 and 2012, there were cumulative undeclared dividends to Preferred Series B shareholders of $71,852 and $63,868, respectively, the obligation for which is contingent on declaration by the board of directors. At December 31, 2013 and 2012, there were accrued unpaid dividends of $15,969 and $15,969, respectively. These balance have been recorded as part of accounts payable and accrued expenses.

Securities Authorized for Issuance under Equity Compensation Plans

The following tables set forth the information as of December 31, 2013 with respect to compensation plans under which our equity securities are authorized for issuance:

EQUITY COMPENSATION PLAN INFORMATION

DECEMBER 31, 2013

Plan Category

Number of shares to be issued

upon exercise of outstanding

options and warrants

Weighted average

exercise

price of outstanding

options

and warrants

Number of securities

available for future

issuance

under equity

compensation

plans (excluding

securities

reflected in column

(a))

(a)

(b)

(c)

Equity compensation plans approved by

security holders:

2003 Stock Option Plan

n/a

2004 Stock Option Plan

n/a

2005 Stock Option Plan

38,164

2.97

38,164

Equity Stock Compensation plan not

approved by security holders:

2006 Employee Compensation Plan

n/a

2008 Amended Incentive Stock Plan

n/a

2,890

2008 SIP – SEC File #333-151258

n/a

2009 Incentive Stock Plan

n/a

374,900

Total

38,164

415,954

Stock Plans

As of December 31, 2013, CoroWare had four stock compensation plans which provided for the issuance of 505,503,333 shares to employees of CoroWare or our subsidiaries as follows:

Plan Description	Authorized Shares		Remaining Shares
2006 Employee Compensation Plan		3,333		-
2008 Incentive Stock Plan		200,000,000		-
2009 Incentive Stock Plan		500,000		-
2010 Incentive Stock Plan (333-165768)		5,000,000		-
2012 Incentive Stock Plan (333-171325)		200,000,000		-
2012 Incentive Stock Plan (333-183512)		50,000,000		-
2013 Incentive Stock Plan (333-186247)		50,000,000		1
Total		505,503,333		1

Stock Options

As of December 31, 2013, we had one active Stock Option Plan known as the 2005 Stock Option Plan. The Plan was approved by our stockholders on November 3, 2006 and authorized the issuance of 66,667 shares of common stock. The Board of Directors on December 31, 2007 cancelled options for 26,367 shares previously granted to current employees prior to that date which were exercisable at various prices and issued 26,367 options to these employees at the closing price as of December 31, 2007 or $3.00. The number of options issued and outstanding under the 2005 plan on December 31, 2013 is 34,831.

In addition to the options issued under the 2005 Stock Option Plan, 26,560 options were issued outside of the Plan. For services rendered, 443 options were issued at a purchase price of $51 per share, 3,833 options were issued at $39 per share, 4,040 options were issued at $15 per share 14,909 options were issued at $33 per share and 3,333 options were issued at $1.86 per share. The only non-plan options that remain outstanding are the 3,333 options that were issued at $1.86 per share.

The following table summarizes stock option activity:

	Total Options		Weighted Average Price
Outstanding, December 31, 2012		38,164	$	2.97
Granted		-		-
Cancelled		-		-
Forfeited		-		-
Exercised		-		-
Outstanding, December 31, 2013		38,164	$	2.97
Exercisable at December 31, 2013		38,164	$	2.97

ITEM 6. SELECTED FINANCIAL DATA.

As a smaller reporting company, as defined in Rule 12-b-2 of the Exchange Act, we are not required to provide the information required by this item.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Cautionary and Forward Looking Statements

This section and other parts of this Form 10-K contain forward-looking statements that involve risks and uncertainties. Forward-looking statements can also be identified by words such as “anticipates,” “expects,” “believes,” “plans,” “predicts,” and similar terms. Forward-looking statements are not guarantees of future performance and CoroWare’s actual results may differ significantly from the results discussed in the forward-looking statements. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included in Item 8 of this Form 10-K. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

There is no assurance that we will be profitable, we may not be able to successfully develop, manage or market our products and services, we may not be able to attract or retain qualified executives and technology personnel, our products and services may become obsolete, government regulation may hinder our business, additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants and stock options, or the exercise of warrants and stock options, and other risks inherent in the our businesses.

We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the factors described in other documents we file from time to time with the Securities and Exchange Commission, including the Quarterly Reports on Form 10-Q and Annual Report on Form 10-K filed by us in 2013 and any Current Reports on Form 8-K filed by us.

CRITICAL ACCOUNTING POLICIES

General

The consolidated financial statements and notes included in our quarterly and annual financial statements contain information that is pertinent to this management's discussion and analysis. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of our assets and liabilities, and affect the disclosure of any contingent assets and liabilities. We believe these accounting policies involve judgment due to the sensitivity of the methods, assumptions, and estimates necessary in determining the related asset and liability amounts. The significant accounting policies are described in the notes to our financial statements and notes included elsewhere in this Form 10-K.

Revenue Recognition

We derive our software system integration services revenue from short-duration, time and material contracts. Generally, such contracts provide for an hourly-rate and a stipulated maximum fee. Revenue is recorded only on executed arrangements as time is incurred on the project and as materials, which are insignificant to the total contract value, are expended. Revenue is not recognized in cases where customer acceptance of the work product is necessary, unless sufficient work has been performed to ascertain that the performance specifications are being met and the customer acknowledges that such performance specifications are being met. We periodically review contractual performance and estimate future performance requirements. Losses on contracts are recorded when estimable. No contractual losses were identified during the periods presented.

We recognize revenue for our software and software professional services when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is probable. Product sales are recognized by us generally at the time product is shipped. Shipping and handling costs are included in cost of goods sold.

We account for arrangements that contain multiple elements in accordance with FASB ASC 605-25, Revenue Recognition, Multiple Element Arrangements. When elements such as hardware, software and consulting services are contained in a single arrangement, or in related arrangements with the same customer, we allocate revenue to each element based on its relative fair value, provided that such element meets the criteria for treatment as a separate unit of accounting. The price charged when the element is sold separately generally determines fair value. In the absence of fair value for a delivered element, we allocate revenue first to the fair value of the underlying elements and allocate the residual revenue to the delivered elements. In the absence of fair value for an undelivered element, the arrangement is accounted for as a single unit of accounting, resulting in a delay of revenue recognition for the delivered elements until the undelivered elements are fulfilled. We limit the amount of revenue recognition for delivered elements to the amount that is not contingent on future delivery of products or services or subject to customer-specified return or refund privileges.

We recognize revenue from the sale of manufacturer’s maintenance and extended warranty contracts in accordance with FASB ASC 605-45, Revenue Recognition, Principal Agent Considerations net of its costs of purchasing the related contracts.

Our ECS revenue is comprised of both services and products. ECS subscription service revenues are generated through the sale of CoroCall™, a managed video conferencing service and CoroCall Communications, a managed telephone service. Our contracts provide for usage pricing or when paid for pre-paid service. We recognize this revenue in the period that the services or minutes are used and prepaid. Product revenues are realized partly through the sale of Vidyo’s product line, including room systems and back-end infrastructure, partly through the sale of CoroWare collaboration products, including CoroWare Usage Reporter for Vidyo, a software package that provides usage statistics for Vidyo brand high-definition video conferencing systems, and partly through the sales of related accessories. Revenues for these products are recognized upon delivery to the customer.

Share-based payment

Stock based compensation expense is recorded in accordance with FASB ASC 718, Compensation – Stock Compensation, for stock and stock options awarded in return for services rendered. The expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight line basis over the service period, which is the vesting period. We estimate forfeitures that we expect will occur and record expense based upon the number of awards expected to vest.

There were no options issued during the years ending December 31, 2013 and 2012.

Derivative Financial Instruments

Derivative financial instruments, as defined in FASB ASC 815, Derivatives and Hedging, consist of financial instruments or other contracts that contain a notional amount and one or more underlying variables (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. The caption Derivative Liability consists of (i) the fair values associated with derivative features embedded in various convertible note financings and (ii) the fair values of the detachable warrants that were issued in connection with those financing arrangements.

We generally do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, we have entered into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by FASB ASC 815, these instruments are required to be carried as derivative liabilities, at fair value, in our financial statements.

We estimate fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, we consider, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, we generally use the Black-Scholes-Merton option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to value these instruments. For complex derivative instruments, such as embedded conversion options, we generally use the Flexible Monte Carlo valuation technique because it embodies all of the requisite assumptions (including credit risk, interest-rate risk and exercise/conversion behaviors) that are necessary to value these more complex instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, our income will reflect the volatility in these estimate and assumption changes.

PLAN OF OPERATION

CoroWare is well positioned for managed growth in Fiscal Year 2014 through continued growth of our CoroWare Business Solutions and Robotics & Automation business units, and rapid growth of our Enterprise Collaboration Solutions business unit.

The CoroWare Business Solutions (CBS) business unit anticipates growing its revenues by delivering business intelligence, software development, IT consulting, lab management and release management professional services through its long term clients, including Microsoft. As well, it anticipates growing its revenues through the sales of products and solutions – such as CoroWare Billing Integration Framework and CoroWare License Manager - that help cloud service providers recognize revenues by delivering conferencing and application services. Additional revenue growth is expected through the sales of enterprise and cloud cyber security solutions.

The Robotics & Automation (R&A) business unit expects to achieve its revenue objectives by offering affordable mobile robotics platforms, products and custom solutions to researchers in the university, commercial and homeland security market segments. As well, the Robotics & Automation group is well positioned to pursue custom engineering opportunities with clients who are developing innovative software services, solutions and products that leverage our expertise in simulation, visualization, mobile robotics, and product realization.

The Enterprise Collaboration Solutions (ECS) business unit plans to rapidly grow its revenues by selling a combination of services and products. Collaboration service revenues are generated through the sale of CoroCall™, a managed business class HD video conferencing service that small, medium and large sized businesses –particularly those in the area of tele-health – are considering as an alternative to purchasing and operating videoconferencing equipment and infrastructure. Product revenues are being realized partly through the sale of Vidyo’s product line – including room systems and back-end infrastructure – partly through the sale of CoroWare collaboration products, partly through the sales of related accessories, and partly through the sales of VidyoCast products and services.

In order to achieve revenue and margin objectives in an increasingly global and competitive market, all of CoroWare’s business units offer their customers the option of using CoroWare’s near-shore resources, which comprise a team of highly capable IT architects, developers and testers with experience in software application development and integration, rich internet applications development, partner management portal development, IT infrastructure, and Quality Assurance.

We do not expect to sell any of CoroWare’s fixed assets, including property or equipment in the next twelve months, nor do we expect to purchase any real property in the next twelve months. During the next twelve months we expect to purchase certain equipment to support software development, testing and continued deployment of CoroWare technologies. Additionally, we expect to purchase office equipment, computer equipment and laboratory development and testing equipment to support our planned personnel increase.

We are internally developing an investor relations program that will help the company communicate more effectively and actively with CoroWare shareholders, and generate greater awareness of CoroWare and our services, solutions and products.

Recent Financing Transactions

As of December 31, 2013 and 2012 the Company had an aggregate total of $515,082 and $504,832, respectively, in notes payable. These notes bear interest at rates ranging from five percent per annum to 21 percent per annum. As of December 31, 2013 all notes payable were in default. Accrued interest on notes payable totaled $617,509 and $532,050 at December 31, 2013 and 2012, respectively.

Notes Payable

(a) Notes payable - Merger:

In February 2003, the Company issued $230,000 of notes payable which matured in June 2003. The notes earn interest at 8% per annum unless they are in default, in which case they earn default interest at a rate of 15%; the notes are currently in default. Additionally, the notes had warrants attached to purchase 11,500 shares of common stock at $15.00 per share and were exercisable through February 12, 2005. None of these warrants were exercised prior to their expiration. During the fourth quarter of 2010, one of these notes with an outstanding balance of $75,000 was sold to a third party by the original investor. The terms of the note were changed such that the note became a convertible debenture [see the $75,000 Collins financing in Note 12(f)]. During 2011, two additional merger notes with an aggregate total of $55,000 were sold to third parties by the original investors and simultaneously converted to convertible debentures [see the $25,000 Tangiers financing in Note 12(p) and the $65,000 Panache financing in Note 12(i)].

(b) Notes payable - Shareholders:

During September through December 2005, the Company entered into short-term debt obligations with shareholders of the Company totaling $257,000. These notes bore interest at rates ranging from 5 to 10 percent per annum and were due between ninety (90) and one hundred twenty (120) days. During the fourth quarter of 2010, the remaining $40,000 of these notes was sold to a third party by the original investor. That third party subsequently converted those notes along with the accrued interest of $7,509 into 15,560,455 shares of common stock of the Company.

Additionally, during 2011 and 2010, the Company entered into various unsecured notes with shareholders with aggregate totals of $5,000 and $45,000, respectively. The notes bear interest at 18% and matured at various dates through June 2011. Repayments of $14,699 and $106,218 ($60,000 in stock) were made during 2011 and 2010, respectively. During 2011, $74,200 of these notes were sold to third parties and simultaneously re-stated as convertible debentures. See Notes 12(b) and 12(e).

During August 2008, the Company entered into two (2) short-term notes with Yorkville that bear interest at 18% and matured in December 2008. This transaction was recorded as an inducement expense of $3,750 during the year ended December 31, 2008. These instruments are in default.

(d) Other notes payable

Other notes payable consist of two notes to third parties. The note bear interest at rates ranging from 0.8 percent to 21 percent and matured through December 31, 2011. Both of these notes are in default.

Convertible Notes Payable

(a) AGS Capital Group, LLC:

On February 25, 2013 the Company borrowed $131,377 from AGS Capital Group, LLC (“AGS”). On April 1, 2013 the Company borrowed an additional $42,000. The notes accrued interest at a rate of 14 percent per annum and became due on February 25, 2014. During the year ended December 31, 2013 the Company made cash payments on the note totaling $2,916. Additionally, AGS converted $12,774 in note principal into 1,159,626,042 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 35 percent discount to the lowest closing price during the 20-day trading period prior to conversion. Accrued interest on the notes totaled $15,877 and $-0- at December 31, 2013 and 2012, respectively.

(b) Asher Enterprises, Inc.:

On February 1, 2011 the Company borrowed $27,500 from Asher Enterprises, Inc. (“Asher”). On August 2, 2012, the Company borrowed an additional $20,000. On August 9, 2012 the Company borrowed an additional $17,500. On October 10, 2012 the Company borrowed an additional $25,000. On January 15, 2013 the Company borrowed an additional $22,500. The notes accrue interest at rates ranging from eight percent to ten percent per annum. At December 31, 2013 each of the notes was past due. During the year ended December 31, 2012 Asher converted $26,725 in note principal into 101,372,149 shares of the Company’s common stock. During the year ended December 31, 2013 Asher converted $18,000 in note principal and $1,100 in accrued interest into 242,222,222 shares of the Company’s common stock. During the year ended December 31, 2013 the Company recognized $37,020 in penalties relating to unpaid principal past maturity dates. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 51 percent discount to the average of the three lowest closing price during the 10-day trading period prior to conversion. Accrued interest on the notes totaled $16,974 and $6,026 at December 31, 2013 and 2012, respectively.

On January 28, 2011 the Company borrowed $10,750 from Barclay Lyons, LLC (“Barclay”). The note accrues interest at a rate of eight percent per annum and is due on demand. Pursuant to the terms of the note the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 50 percent discount to the lesser of the closing price on the day prior to conversion and the volume-weighted-average closing price of the five day trading period prior to conversion. Accrued interest on the note totaled $9,724 and $7,479 at December 31, 2013 and 2012, respectively.

(d) Blackbridge Capital, LLC:

On July 10, 2013 the Company borrowed $3,000 from Blackbridge Capital, LLC (“Blackbridge”). During the year ended December 31, 2013 Blackbridge purchased a $67,042 convertible note for which the Company is the borrower. The notes accrue interest at a rate of ten percent per annum. During the year ended December 31, 2013 Blackbridge converted $18,000 in note principal into 258,214,285 shares of the Company’s common stock. The remaining unpaid principal is past due. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a price equal to the average closing price during the 20-day trading period prior to conversion. Accrued interest on the notes totaled $27,108 and $17,868 at December 31, 2013 and 2012, respectively.

(e) Cariou, Raphael:

On April 4, 2011 the Company borrowed $89,383 from Raphael Cariou (“Cariou”). On August 3, 2012 the Company borrowed an additional $7,000 and made payments on the note totaling $28,239. During the year ended During the year ended December 31, 2013 the Company made payments of $30,000 against note principal. The notes accrue interest at a rate of ten percent per annum. As of December 31, 2013 the unpaid principal is past due. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a price equal to the average closing price during the five-day trading period prior to conversion, multiplied by 115 percent. Accrued interest on the notes totaled $23,375 and $21,216 at December 31, 2013 and 2012, respectively.

(f) Collins, Thomas:

On December 6, 2010 the Company borrowed $84,168 from Thomas Collins (“Collins”). The Company made payments on the note totaling $44,998. The note accrues interest at a rate of eight percent per annum and is due on demand. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 70 percent discount to the average of the three lowest closing price during the ten-day trading period prior to conversion. Accrued interest on the notes totaled $18,389 and $12,545 at December 31, 2013 and 2012, respectively.

(g) Kellburgh, Ltd.:

On February 21, 2012 the Company borrowed $13,000 from Kellburgh, Ltd (“Kellburgh”). The note accrues interest at a rate of ten percent per annum and became due on March 22, 2012. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 15 percent discount to the average of the three lowest closing price during the five-day trading period prior to conversion. Accrued interest on the notes totaled $1,289 and $-0- at December 31, 2013 and 2012, respectively.

(h) Magna Group, LLC:

On August 20, 2012 the Company borrowed $10,000 from Magna Group, LLC (“Magna”). During the year ended December 31, 2013 the Company converted the entire principal balance into 94,000,000 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance was convertible at the option of the note holder into shares of the Company’s common stock at a 60 percent discount to the lowest closing price during the three-day trading period prior to conversion. As of December 31, 2013 the note had been satisfied in full.

(i) Panache Capital, LLC:

On June 2, 2011 the Company borrowed $65,000 from Panache Capital, LLC (“Panache”). On June 29, 2011 the Company borrowed an additional $15,000. The notes accrue interest at a rate of eight percent per annum and became due in June, 2012. During the year ended December 31, 2012 the Company converted $16,719 of the principal into 28,275,000 shares of the Company’s common stock. During the year ended December 31, 2013 the Company converted $22,197 of the principal into 298,600,000 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance was convertible at the option of the note holder into shares of the Company’s common stock at a 15 percent discount to the average of the three lowest closing prices during the 20-day trading period prior to conversion. Accrued interest on the notes totaled $14,532 and $10,367, respectively.

(j) Premier I.T. Solutions Corp.:

On October 5, 2011 the Company borrowed $21,962 from Premier I.T. Solutions Corp. (“Premier”). The note accrues interest at a rate of 10 percent per annum and became due on March 5, 2012. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at the average of the closing prices during the five-day trading period prior to conversion, multiplied by 115 percent. Accrued interest on the notes totaled $6,958 and $3,555, respectively.

(k) Ratzker, David:

On July 20, 2009 the Company borrowed $568,263 from David Ratzker (“Ratzker”). The note accrues interest at a rate of 14 percent per annum and became due on December 31, 2010. During the year ended December 31, 2012 the Company made payments on the note totaling $128,224 and converted $3,900 of the principal balance into 60,000,000 shares of the Company’s common stock. During the year ended December 31, 2013 the Company made payments on the note totaling $112,823 and converted $17,550 of accrued interest into 220,000,000 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at the lowest volume-weighted-average closing price during the 20-day trading period prior to conversion. Accrued interest on the notes totaled $124,554 and $125,021, respectively.

(l) Redwood Management, LLC:

On March 21, 2011 the Company borrowed $284,132 from Redwood Management, LLC (“Redwood”). The note accrues interest at a rate of 14 percent per annum and became due on March 18, 2013. During the year ended December 31, 2012 the Company converted $44,935 of the principal balance into 608,596,847 shares of the Company’s common stock. During the year ended December 31, 2013 the Company converted $35,250 of note principal into 279,048,581 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 35 percent discount to the lowest volume-weighted-average closing price during the 20-day trading period prior to conversion. Accrued interest on the notes totaled $12,855 and $9,947, respectively.

(m) Ridgepoint Capital:

On August 30, 2012 the Company borrowed $54,060 from Ridgepoint Capital (“Ridgepoint”). The notes accrue interest at rates of 20 percent per annum and become due on June 7, 2014. On June 7, 2013 the Company borrowed an additional $36,250. This note accrues interest at a rate of ten percent per annum and became due on March 24, 2013. During the year ended December 31, 2012 the Company converted $4,970 of the principal balance 25,000,000 shares of the Company’s common stock. During the year ended December 31, 2013 the Company converted $21,625 of note principal into 425,000,000 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 65 percent discount to the average of the two lowest closing prices during the five-day trading period prior to conversion. Accrued interest on the notes totaled $8,032 and $1,639, respectively.

(n) Sobeck, Michael:

On October 9, 2012 the Company borrowed $35,000 from Michael Sobeck (“Sobeck”). The note accrues interest at a rate of $500 per week and becomes due on November 30, 2012. During the year ended December 31, 2012 the Company made cash payments totaling $6,500 against note principal. During the year ended December 31, 2013 the Company converted $13,962 of note principal into 279,248,800 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 50 percent discount to the lowest closing price during the ten-day trading period prior to conversion. Accrued interest on the notes totaled $28,000 and $2,000, respectively.

(o) Tangiers Investment Group, LLC:

On March 9, 2013 the Company borrowed $17,000 from Tangiers Investment Group, LLC (“Tangiers Investments”). On March 11, 2013 the Company borrowed an additional $12,373. On April 19, 2013 the Company borrowed an additional $14,000. On May 1, 2013 the Company borrowed an additional $24,893 and on May 17, 2013 borrowed an additional $20,000. The notes accrue interest at a rate of ten percent per annum and becomes due one year from the note date. During the year ended December 31, 2013 the Company converted $25,375 of note principal into 510,234,000 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 50 percent discount to the lowest closing price during the ten-day trading period prior to conversion. Accrued interest on the notes totaled $4,442 and $-0- as of December 31, 2013 and 2012, respectively.

(p) Tangiers Investors, LP:

On May 16, 2011 the Company borrowed $10,000 from Tangiers Investors, LP (“Tangiers Investors”). On June 10, 2011 the Company borrowed an additional $15,000. On March 7, 2012 the Company borrowed an additional $16,915. On March 8, 2012 the Company borrowed an additional $21,000. The notes accrue interest at rates from seven to ten percent per annum and became due one year from the note date. At December 31, 2013 each of the notes was overdue. During the year ended December 31, 2012 the Company converted $38,246 of note principal and $1,748 of accrued interest into 23,609,250 shares of the Company’s common stock. During the year ended December 31, 2013 the Company converted $24,669 of note principal and $2,045 of accrued interest into 198,041,345 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 50 percent discount to the lowest closing price during the ten-day trading period prior to conversion. At December 31, 2013 each of the notes, including accrued interest, had been satisfied in full.

(q) Westmount International Holdings:

On January 12, 2010 the Company borrowed $884,710 from Westmount International Holdings (“Westmount”). The note accrues interest at a rate of 14 percent per annum and is due on demand. During the year ended December 31, 2013 the Company converted $3,263 of note principal into 19,196,530 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 15 percent discount to the lower of $0.02 per share and the lowest volume-weighted-average closing price during the 30-day trading period prior to conversion. Accrued interest on the notes totaled $541,236 and $469,275 as of December 31, 2013 and 2012, respectively.

(r) Y.A. Global Investments, LP:

On December 7, 2006 the Company borrowed $1,000,000 from Y.A. Global Investments, LP (“Y.A. Global”). On November 2, 2007 the Company borrowed an additional $600,000. Both of these notes became due in 2009. On March 7, 2013 the Company borrowed an additional $25,000, becoming due on March 7, 2014. The notes accrue interest at a rate of 14 percent per annum. During the year ended December 31, 2012 the Company converted $6,715 of note principal into 79,000,000 shares of the Company’s common stock. During the year ended December 31, 2013 the Company converted $31,110 of note principal into 304,037,255 shares of the Company’s common stock. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 20 percent discount to the lowest volume-weighted-average closing price during the 30-day trading period prior to conversion. Accrued interest on the notes totaled $1,073,806 and $962,533 as of December 31, 2013 and 2012, respectively.

(s) Zoom Marketing Corporation:

On August 23, 2013 the Company borrowed $140,000 from Zoom Marketing Corporation (“Zoom”). The note accrues interest at a rate of five percent per annum and became due on January 23, 2014. Pursuant to the terms of the notes the principal balance is convertible at the option of the note holder into shares of the Company’s common stock at a 15 percent discount to the lowest closing price during the ten-day trading period prior to conversion. Accrued interest on the notes totaled $2,436 and $-0- as of December 31, 2013 and 2012, respectively.

RESULTS OF OPERATIONS

YEAR ENDED DECEMBER 31, 2013 COMPARED TO YEAR ENDED DECEMBER 31, 2012:

During the year ended December 31, 2013 (the "2013 Period") revenues were $1,067,229 compared to revenues of $1,276,022 during the year ended December 31, 2012 (the "2012 Period”). Revenues in the 2013 period were lower compared to the 2012 period as the Company reorganized its business management and sales teams in order to grow sales in the following fiscal year.

Cost of goods sold was $761,413 and $851,385 for the 2013 Period and the 2012 Period, respectively. Cost of goods sold primarily represents labor and labor-related costs in addition to overhead costs. The increased cost of goods sold was principally due to product returns in the 4th quarter of the 2013 Period. The Company began to reorganize its product development and business management teams at the end of the 2013 Period in order to improve sales and product quality in the following fiscal year

Gross Profits decreased to $305,816 during the 2013 Period compared to $424,637 during the 2012 Period. Gross profits decreased during the 2013 Period as a result of Gross revenues declining. The Gross profit percentage in the 2013 Period was 29% compared to 33% in the 2012 period.

Operating expenses were $1,678,207 for the 2013 period compared to $788,355 for the 2012 period. General and administrative expenses amounted to $1,439,421 during the 2013 Period compared to $425,446 for the 2012 period, and represented mostly labor and related compensation costs, legal and professional fees, outside services, travel expenses, rental expense and related office expenses. Sales and marketing expenses were $212,371 for the 2013 period compared to $291,961 for the 2012 period. Research and developments costs totaled $23,415 for the 2013 period compared to $58,948 during the 2012 period. Depreciation and amortization costs were $3,000 for the 2013 period compared to $12,000 for the 2012 period.

Loss from operations was $1,372,391 for the 2013 period compared to $363,718 for the 2012 period. Loss from operations was lower in the 2013 Period due primarily to a significant decrease in general and administrative expenses and, a modest decrease in sales revenues throughout the 2013 period.

Other income (expense) was $923,580 during the 2013 period compared to other expense of $3,647,270 in the 2012 period. Other income (expense) is comprised primarily of gain/loss on derivative and amortization of debt discount and deferred finance costs. The gain on derivative for the 2013 period was $4,985,720 compared to a loss of $2,597,552 for the 2012 period. The embedded conversion features associated with our convertible debentures are valued based on the number of shares that are indexed to that liability. Keeping the number of shares constant, the liability associated with the embedded conversion features increases as our share price increases and, likewise, decreases when our share price decreases. Derivative income (expense) displays the inverse relationship. Interest expense for the 2013 period was $5,909,300 compared to $1,068,507 for the 2012 period. The Company also recognized a $71,069 gain on extinguishment of debt during the 2012 period. The increase in interest expense is principally a result of an increase in the amount of debt discount that was amortized and derivative valuations in excess of debt discount amounts. The debt discount is being amortized using the effective interest method. Under this method, the amount of amortization increases exponentially as the underlying carrying value of the amortized debt increases.

Net loss for the 2013 period was $2,323,226 compared to net loss of $3,980,286 for the 2012 period.

LIQUIDITY AND CAPITAL RESOURCES

During the year ended December 31, 2013 (the "2013 period") we used $434,618 net cash from operating activities compared to $57,191 for the year ended December 31, 2012 (the "2012 period").

During the year ended December 31, 2013 (the "2013 period") we used $367 net cash from investing activities compared to $3,121 for the year ended December 31, 2012 (the "2012 period") for purchases of property and equipment.

In the 2013 period, the Company generated $432,231 in cash from financing activities. This primarily reflects borrowings on convertible debentures. The Company's financing activities generated $62,544 of cash during the 2012 period.

At December 31, 2013, we had current assets of $24,710, current liabilities of $14,434,511, negative working capital of $14,409,801 and an accumulated deficit of $41,373,974. At December 31, 2012, we had current assets of $129,766, current liabilities of $13,947,222, negative working capital of $13,817,456 and an accumulated deficit of $39,050,748.

We presently do not have any available credit, bank financing or other external sources of liquidity. We will need to obtain additional capital in order to expand operations and become profitable. In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding. We will still need additional capital in order to continue operations until we are able to achieve positive operating cash flow. Additional capital is being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity, or capital expenditures.

CONTRACTUAL OBLIGATIONS

The following table sets forth the contractual obligations of the Company as of December 31, 2013:

	Payments due by Period
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years

Convertible debt	$	2,452,430	$	2,452,430	$	-	$	-	$	-
Notes payable		515,082		515,082		-		-		-
Notes payable, related parties		218,275		218,275		-		-		-
Small Business Administration loan		980,450		980,450		-		-		-
	$	3,896,029	$	3,896,029	$	-	$		$

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this item.

ITEM 8. FINANCIAL STATEMENTS

All financial information required by this Item is attached hereto at the end of this report beginning on page F-1 and is hereby incorporated by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES

None.

ITEM 9A-(T). CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this annual report on Form 10-K, management performed, with the participation of our Chief Executive Officer and our Chief Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on the evaluation and the identification of the material weaknesses in internal control over financial reporting described below our Chief Executive Officer and our Chief Financial Officer concluded that, as of December 31, 2013, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act.) Internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive officer and principal financial officer and effected by an entity’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

●	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the entity;
●	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the entity are being made only in accordance with authorizations of management and directors of the entity; and
●	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the entity’s assets that could have a material effect on its consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the Company’s management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in the Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission.

Based upon this assessment, as of December 31, 2013 the Company’s management concluded that there are material weaknesses affecting our internal control over financial reporting and have concluded that our internal control over financial reporting was not effective as of the end of the period covered by this report.

The matters involving internal controls and procedures that our management considers to be material weaknesses under COSO and Commission rules are: (1) lack of a functioning audit committee and lack of independent directors on our board of directors, resulting in potentially ineffective oversight in the establishment and monitoring of required internal controls and procedures; (2) inadequate segregation of duties consistent with control objectives; (3) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and (4) ineffective controls over period end financial disclosure and reporting processes. The aforementioned potential material weaknesses were identified by our Chief Financial Officer in connection with the preparation of our financial statements as of December 31, 2013 who communicated the matters to our management and board of directors.

Management believes that the material weaknesses set forth in items (2), (3) and (4) above did not have an effect on our financial results. However, the lack of a functioning audit committee and lack of a majority of independent directors on our board of directors, resulting in potentially ineffective oversight in the establishment and monitoring of required internal controls and procedures, can impact our financial statements.

Attestation Report of Independent Registered Public Accounting Firm

This annual report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to an exemption for non-accelerated filers set forth in Section 989G of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

Management’s Remediation Initiatives

Although we are unable to meet the standards under COSO because of the limited resources available to a company of our size, we are committed to improving our financial organization. As funds become available, we will undertake to: (1) create a position to segregate duties consistent with control objectives, (2) increase our personnel resources and technical accounting expertise within the accounting function (3) appoint one or more outside directors to our board of directors who shall be appointed to a Company audit committee resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures; and (4) prepare and implement sufficient written policies and checklists which will set forth procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements.

We will continue to monitor and evaluate the effectiveness of our disclosure controls and procedures and our internal control over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow. However, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks.

The implementation of these and other initiatives will be largely contingent on our ability to expand our board of directors and create audit and compensation committees. As we build an independent board-majority, comprised of a number of financial professionals, we anticipate the planning and implementation of internal controls to be expedited and improved.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Auditor’s Attestation

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Our directors, principal executive officers and significant employees as of December 31, 2013 are as specified on the following table:

Name		Age		Position
Lloyd Spencer		57		Chief Executive Officer, Interim Chief Financial Officer, Director, Treasurer, Secretary

The principal occupations for each of our current executive officers and directors are as follows:

LLOYD T. SPENCER became our Chief Executive Office on January 28, 2008, interim Chief Financial Officer on November 17, 2008 and a member of the board of directors and Vice President since September 20, 2007. Beginning in May 2006, Mr. Spencer has served as President and CEO of our subsidiary, CoroWare Technologies, Inc. Beginning in October 2004, Mr. Spencer was co-founder and President of CoroWare, Inc., a Washington State private company that was acquired by Innova Holdings, Inc., which is now known as CoroWare, Inc. From June 2002 to September 2004, Mr. Spencer was Vice President of Sales at Planet Technologies, a systems integration company based in Germantown, MD. From November 1996 to August 2001, Mr. Spencer was Solutions Unit Manager and Group Product Manager at Microsoft in Redmond, Washington. Prior to Microsoft, Mr. Spencer served as Assistant Vice-President and Business Unit Manager at Newbridge Networks; and Product Line Manager at Sun Microsystems. He is an active contributor to the robotics community in the Seattle area through his participation in the Seattle Robotics Society. He is also instrumental in initiating and fostering 4H robotics clubs and programs in Washington State. Mr. Spencer received his Bachelors degree from Cornell University in 1980 with a major in Biology and Animal Science and with an emphasis in Immunogenetics.

On February 14, 2014, Ms. Shanna Gerrard resigned as Corporate Secretary of CoroWare, Inc. (the “Company”), effective immediately. There was no disagreement between the Company and Ms. Gerrard which led to her resignation.

On February 14, 2014, Mr. Lloyd Spencer,,Chairman of the Board of Directors, was appointed as Interim Corporate Secretary. Mr. Spencer continues to serve as President and Chief Executive Officer.

Our director will serve until the next annual meeting of stockholders. Our executive officers are appointed by our Board of Directors and serve at the discretion of the Board of Directors.

Section 16(a) of the Securities and Exchange Act of 1934

Section 16 (a) of the Securities and Exchange Act of 1934 requires the Company’s officers and directors and persons who beneficially own more than 10% of the Company’s common stock (collectively, “Reporting Persons”) to file reports of beneficial ownership and changes in beneficial ownership with the SEC. Reporting Persons are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file. We believe that all Reporting Persons complied with all applicable reporting requirements, except for the late filings of Form 3 (Initial Statement of Beneficial Ownership of Securities), and 4 (Statement of Changes of Beneficial Ownership of Securities) filings of Lloyd Spencer and Shanna Gerrard.

CODE OF ETHICS DISCLOSURE COMPLIANCE

CoroWare has adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer and other employees performing similar functions. The Code of Ethics was revised and updated in 2007 and approved by the board on December 6, 2007. The Code of Ethics is in the investor section of our website at www.coroware.com .

ITEM 11. EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth the cash compensation (including cash bonuses) paid or accrued and equity awards granted by CoroWare for years ended December 31, 2013 and 2012 to our Chief Executive Officer and our two most highly compensated officers other than the Chief Executive Officer at December 31, 2013 whose total compensation exceeded $100,000.

Name & Principal Position	Year	Salary		Bonus		Stock Awards		Option Awards		Non-equity Incentive Plan Compensation		Change in Pension Value and Non- Qualified Deferred Compensation Earnings		All other Compensation		Totals
Lloyd Spencer (1)	2013		34,858	$	-	$	-	$	-	$	-	$	-	$	-	$	34,858
	2012	$	26,639													$	26,639
David Hyams (2)	2013	$	49,883			$	3,417									$	53,300
	2012	$	62,374			$	11,879									$	74,253

Notes:

	(1)	Lloyd Spencer has served as CEO since January 28, 2008 and interim CFO since November 17, 2008. Prior to that, he was Vice President of Business Development and Director. Mr. Spencer is President of our subsidiary, CoroWare Technologies, Inc. with an annual salary of $150,000. On May 16, 2006, Mr. Spencer entered into an employment agreement which granted him 1,667 stock options to purchase restricted shares of CoroWare’s common stock at $54 which were cancelled on December 31, 2007 and converted into restricted common stock one-for-one and issued in lieu thereof by action of the Board of Directors. Mr. Spencer was granted 1,667 options to purchase restricted shares of CoroWare common stock at $12 on May 16, 2006. These options have a ten year term and vest ratably over three years. On December 31, 2007 the options were re-priced from $12 to $3. In February 2008, these options were converted to 1,667 shares of CoroWare common stock. On September 12, 2007, Mr. Spencer was granted options to purchase restricted shares of the CoroWare common stock at $12 per share. On December 31, 2007, the options were re-priced from $12 to $3. As of December 31, 2010, all 5,000 of these options have vested.
	(2)	David Hyams is Chief Technology Officer with a salary of $150,000. On May 16, 2006, Mr. Hyams entered into an employment agreement which granted him 1,667 stock options to purchase restricted shares of CoroWare’s common stock at $54 which were cancelled on December 31, 2007 and converted into restricted common stock one-for-one and issued in lieu thereof by action of the Board of Directors. Mr. Hyams was granted 1,667 options to purchase restricted shares of CoroWare common stock at $12 on May 16, 2006. These options have a ten year term and vest ratably over three years. On December 31, 2007 the options were re-priced from $12 to $3. In February 2008, these options were converted to 1,667 shares of CoroWare common stock. On September 12, 2007, Mr. Hyams was granted options to purchase restricted shares of the CoroWare common stock at $12 per share. On December 31, 2007, the options were re-priced from $12 to $3. As of December 31, 2010, all 5,000 of these options have vested. In 2012, Mr. Hyams agreed to a modification of his employment contract which changed his salary to an hourly rate resulting in gross income of $126,000 per year of which a portion is paid in cash as noted in the table above and a portion is deferred.

Stock Option Plans

CoroWare’s 2005 Stock Option Plan was ratified by the Stockholders of the Corporation at a Special Meeting of the Stockholders on November 3, 2006. The plan is presently administered by our board of directors, which selects the eligible persons to whom options shall be granted, determines the number of common shares subject to each option, the exercise price therefore and the periods during which options are exercisable, interprets the provisions of the plan and, subject to certain limitations, may amend the plan. Each option granted under the plan shall be evidenced by a written agreement between the company and the optionee. Options may be granted to employees (including officers) and directors and certain consultants and advisors. Options granted under the plan are not transferable, except by will and the laws of descent and distribution.

Name	Number of Shares Underlying Options	% of Total Options Granted to Employees	Exercise Price	Expiration Date
Lloyd Spencer (See Note 1)	25	14.2%	$ 600.00	9/12/2017
David Hyams (see Note2)	25	14.2%	$ 600.00	9/12/2017

Notes:

(1) Lloyd Spencer has served as CEO since January 28, 2008 and interim CFO since November 17, 2008. Prior to that, he was Vice President of Business Development and Director. Mr. Spencer is President of our subsidiary, CoroWare Technologies, Inc. with an annual salary of $150,000. On May 16, 2006, Mr. Spencer entered into an employment agreement which granted him 1,667 stock options to purchase restricted shares of CoroWare, Inc.’s common stock at $54 which were cancelled on December 31, 2007 and converted into restricted common stock one-for-one and issued in lieu thereof by action of the Board of Directors. Mr. Spencer was granted 1,667 options to purchase restricted shares of our. common stock at $12 on May 16, 2006. These options have a ten year term and vest ratably over three years. On December 31, 2007 the options were re-priced from $12 to $3. In February 2008, these options were converted to 1,667 shares of our common stock. On September 12, 2007, Mr. Spencer was granted options to purchase restricted shares of our common stock at $12 per share. On December 31, 2007, the options were re-priced from $12 to $3. As of December 31, 2012, all 5,000 of these options have vested.

(2) Mr. Hyams entered into an employment agreement and was granted 1,667 options to purchase restricted shares of the Company’s common stock at a purchase price of $54, expiring in ten years, and vesting ratably over three years. The Board of Directors voted to re-price these options to $12 at September 12, 2007 and again to $3 at December 31, 2007. On February 4, 2008 these options were converted into 1,667 share of the Company’s common stock as per a directive from our board of directors. On September 12, 2007 Mr. Hyams was grated 5,000 options to purchase restricted shares of CoroWare common stock at $12 per share. On December 31, 2007 the options were re-priced $3. At December 31, 2012, all 5,000 of those options are vested.

Except as described above no other equity awards were made in 2013and 2012 to any of the Executive Officers.

Outstanding Equity Awards at Year End

The following table sets forth information for the named executive officers regarding the number of options and stock awards, as well as the exercise prices and expiration dates thereof, as of December 31, 2013.

Option Awards											Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable (1)		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)		Option Exercise Price ($)		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)		Market Value of Shares or Units of Stock That Have Not Vested ($)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)
Lloyd Spencer		5,000		-		-	$	3		9/2017		-		-		-		-
David Hyams		5,000		-		-	$	3		9/2017		-		-		-		-

(1) These awards rest ratably over three years from the date of grant and are exercisable for ten years.

Director's Compensation

CoroWare, Inc. has not paid and does not presently propose to pay cash compensation to any director for acting in such capacity. For 2012 and 2012 services, each director was awarded 4,500,000 restricted shares of our common stock. In addition, the chairman was awarded 2,250,000 shares. Neither director has received his shares for 2012, nor for 2012 services. A liability has been established for $9,374 for the remaining board fees that have yet to be paid.

The directors received the following common stock issuances for their service in 2013 and 2012:

Director

Restricted

Common

Stock Issued

in 2013 for

services

Value

Restricted

Common

Stock Issued

in 2012 for

services

Value

Martin Nielson

John Kroon

Total

Employment Agreements with Executive Officers

Currently there is an employment agreement with Lloyd Spencer, CEO and interim CFO of CoroWare, Inc., and President and CEO of CoroWare Technologies, Inc. We entered into a five year employment agreement with Mr. Spencer on May 16, 2006. Under the terms of this agreement, Mr. Spencer is to serve as the President of CoroWare and to provide services as needed. His salary is $150,000 per annum. During 2012, Mr. Spencer reduced his annual salary to $59,541, of which $40,000 was deferred. During 2012, an additional $17,650 was deferred. An annual bonus may be awarded at the discretion of the board of directors. At the inception of the agreement, Mr. Spencer was awarded 16,667 stock options to purchase CoroWare, Inc. common stock at $5.40 per share. These options vest annually over three years and terminate on the tenth anniversary of the date of grant.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information regarding the beneficial ownership of our common stock as of August 21, 2014 by each person or entity known by us to be the beneficial owner of more than 5% of any class of our voting securities, each of our directors and named executive officers, and all of our directors and executive officers as a group. Beneficial ownership has been determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended. Generally, a person is deemed to be the beneficial owner of a security if he has the right to acquire voting or investment power within 60 days.

Percentage ownership in the following table is based on 13,149,707,329 shares of common stock outstanding and 100,000 shares of Series D Convertible Preferred Stock outstanding as of August 21, 2014. A person is deemed to be the beneficial owner of securities that can be acquired by that person within 60 days from April 11, 2013 upon the exercise of options, warrants or convertible securities, or other rights. Each beneficial owner's percentage ownership is determined by dividing the number of shares beneficially owned by that person by the base number of outstanding shares, increased to reflect the shares underlying options, warrants, convertible securities, or other rights included in that person's holdings, but not those underlying shares held by any other person.

Name and Address of Beneficial Owner	Amount and Nature of Common Stock Beneficial Ownership	Percent of Class
Lloyd Spencer
18529 NE 184 th Street	60,606,335	< 1%
Woodinville, WA 98072
Directors and Officers as a Group (1 person)	60,606,335	< 1%

Name of Series D Stockholder	Number of Shares of Common Stock Held	Number of Shares of Series D Preferred held(1)		Number of Votes held by such Series D Stockholder		Number of Votes		Percentage of the Voting Equity
Lloyd Spencer	60,606,335		60,000		x 100,000		6,060,606,335		46.0	%
Shanna Gerrard	25		20,000		x 100,000		2,000,000,025		15.0	%
Jared Robert	86,501		20,000		x 100,000		2,000,086,501		15.0	%

(1)

Each share of Series D Convertible Preferred Stock (“Series D Preferred”) has the equivalent of one hundred thousand (100,000) votes of common stock. Currently, there are 3 holders of Series D Preferred Stock, namely Lloyd Spencer (60,000 shares), Shanna Gerrard (20,000 shares) and Jared Robert (20,000 shares) (together, the “Series D Stockholders”), collectively holding 100,000 shares of Series D Preferred, resulting in the Series D Stockholders holding in the aggregate a majority of the total voting power of all issued and outstanding voting shares of the Company.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

No director, executive officer or nominee for election as a director of our company, and no owner of five percent or more of our outstanding shares or any member of their immediate family has entered into or proposed any transaction in which the amount involved exceeds $60,000 except as set forth below.

During October 2007, several current directors and officers invested $35,000 in Series C preferred stock, which is described in Note 12 in the notes to financial statements. In April 2008, all of the Series C preferred shareholders converted their investments into CoroWare common stock.

We also entered into short-term debt obligations other than in the ordinary course of business. The following table sets forth the pertinent information relating to the obligations:

Lender	Interest Rate			Original Amount of Loan		Outstanding Balance at December 31, 2013		Date of Loan	Due Date
Rick Wynns		5	%	$	27,500	$	-	Jul 22, 2005	Dec 31, 2007
Rick Wynns		21	%	$	25,000	$	25,000	Jul 27, 2010	Jan 23, 2012
Amy Spencer		18	%	$	50,000	$	50,000	Jul 3, 2008	Dec 20, 2008

Raphael Cariou		18	%	$	87,900	$	-	Jul 3–Dec 19, 2008	Various dates thru April, 2012
John Kroon		18	%	$	10,000	$	10,000	Mar 17, 2010	Sep 13, 2010
Lloyd Spencer		18	%	$	223,629	$	123,275	Feb 2 – Aug 14, 2009	Various dates thru Mar 16, 2010

On July 22, 2005 CoroWare borrowed $30,000 from a beneficial shareholder and then-director, Rick Wynns, and entered into a short term note requiring interest at the annual rate of 5%, maturing in six months, and principal and accrued interest are convertible into CoroWare common stock at $0.15 per share. A payment of $2,500 was made during the 4th quarter of 2006. The due date of the note was extended to December 31, 2008. To date there have been no conversions. In addition in October 2005 we entered into a second short-term obligation with Mr. Wynns for $30,000. The note bears interest at 10% and matured in April 2006. A $20,000 principal payment was made on this note in May 2006. The due date of the note was extended to December 31, 2007. In October 2005, we entered into a third short-term obligation with Mr. Wynns for $30,000. This note bears interest at 10% and also matured in April 2006. This note was also extended through December 31, 2007. During the 4 th quarter of 2010, Mr. Wynns sold $40,000 of these notes to an outside third party and then made an additional loan to the Company of $25,000 bearing interest at 21% and maturing January 23, 2012. That note is currently in default.

In July 2008 CTI entered into a short-term debt obligation totaling $50,000 with Amy Spencer. The entire balance of the loan plus accrued interest at 1.5% per month was due on December 20, 2008. The note was not paid at maturity and is currently accruing late fees of 0.5% per month in addition to the interest.

During 2008, CoroWare borrowed an aggregate $62,900 from Raphael Cariou, a shareholder and employee of CoroWare. The notes bear interest at 18% and mature on various dates beginning December 20, 2008 and running through June 30, 2009. Cash payments of $6,200 were made during 2010. All of the notes are currently in default and accruing late fees of 0.5% per month in addition to the interest.

During 2009, CoroWare borrowed an aggregate $223,629 from Lloyd Spencer, our CEO and a shareholder. The notes bear interest at 18% and mature on various dates from July 2009 through March 2010. During 2010, the Company made cash payments of $40,018 towards these loans and issued 10,000,000 shares of stock valued at $50,000. All of the remaining notes are currently in default and accruing late fees of 0.5% per month in addition to the interest.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

(1) Audit Fees

The aggregate fees billed for professional services rendered by Sadler, Gibb & Associates, LLC for the audit of the Registrant's annual consolidated financial statements and review of the interim financial information included in the Registrant's Forms 10-Q or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for fiscal years 2013 and 2012, were $50,500 and $-0-, respectively.

The aggregate fees billed for professional services rendered by Lake & Associates CPAs LLC for the audit of the Registrant's annual consolidated financial statements and review of the interim financial information included in the Registrant's Forms 10-Q or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for fiscal years 2013 and 2012, were $4,000 and $50,700, respectively.

(2) Tax Fees

The aggregate fees billed for professional services rendered for the preparation of the Registrant's tax returns, including tax planning for fiscal years 2013 and 2012 were $-0- and $-0-, respectively.

(3) All Other Fees

No other fees were paid to Lake & Associates CPAs LLC or Sadler, Gibb & Associates for fiscal years 2013 and 2012.

(4) Audit Committee Policies and Procedures

The Registrant does have an audit committee. The Board of Directors of the Registrant approved all of the services rendered to the Registrant by Lake & Associates for fiscal years 2013 and 2012.

(5) Audit Work Attributed to Persons Other Lake & Associates CPAs LLC and Sadler, Gibb & Associates, LLC

Not applicable.

PART IV

ITEM 15. EXHIBITS

Exhibit		Description

2.4		Agreement and Plan of Merger among the Company, RWT Acquisition, Inc and Robotic Workspace Technologies, Inc. dated July 21, 2004. (5)

3.1		Articles of Incorporation (2)

3.1.1		Amendment to Articles of Incorporation as of January 3, 2012

3.2		Bylaws (2)

4.1		Certificate of Designation of Series D Convertible Preferred Stock dated November 10, 2012 ( )

4.2		Certificate of Designation of Series E Convertible Preferred Stock dated March 9, 2012 ( )

10.17		Registration Rights Agreement with Cornell Capital Partners, LP dated June 14, 2005 (10)

10.18		Escrow Agreement with Cornell Capital Partners, LP and David Gonzalez, Esq. dated June 14, 2005 (10)

10.19		Promissory Note for $300,000 issued to Cornell Capital Partners, LP dated June 14, 2005 (10)

10.21		Securities Purchase Agreement with Cornell Capital Partners, LP dated October 7, 2005 (11)

10.22		Registration Rights with Cornell Capital Partners, LP dated October 7, 2005 (11)

10.23		Convertible Debenture issued to Cornell Capital Partners, LP dated October 7, 2005 (11)

10.24		Security Agreement with Cornell Capital Partners, LP dated October 7, 2005 (11)

10.25		Escrow Agreement with David Gonzalez and Cornell Capital Partners, LP dated October 7, 2005 (11)

10.28		Stock Option Plan adopted on April 12, 2005 and amended on April 12, 2006 (14)

10.29		Amended and Restated Stock Option Plan amended on July 24, 2006 (15)

10.30		Convertible Debenture dated July 21, 2006 (16)

10.31		Form of $0.05 Warrant (16)

10.32		Form of $0.10 Warrant (16)

10.33		Form of $0.025 Warrant (16)

10.34		Form of $0.065 Warrant (16)

10.35		Form of $0.075 Warrant (16)

10.36		Securities Purchase Agreement dated July 21, 2006 between the Company and Cornell (16)

10.37		Investor Registration Rights Agreement dated July 21, 2006 between the Company and Cornell (16)

10.38		Security Agreement dated July 21, 2006 by and between the Company and Cornell (16)

10.39		Subsidiary Security Agreement dated July 21, 2006 by and between CoroWare Technologies, Inc. and Cornell (16)

10.41		Asset Purchase Agreement by and among Innova Holdings, Inc., CoroWare Technologies Inc. and CoroWare, Inc. dated May 12, 2006. (18)

10.42		Form of Executive Employment Agreement. (18)

10.44		Conversion Agreement dated as of October 19, 2007, by and between Innova Robotics and Automation, Inc. and Jerry Horne (22)

10.45		Securities Purchase Agreement, dated October 25 t , 2007 (22)

10.46		Secured Convertible Debenture, dated October 25 th , 2007 (22)

10.47		Redemption Warrant, dated October 25 th , 2007 (22)

10.48		Registration Rights Agreement, dated October 25 th , 2007 (22)

10.49		Security Agreement, dated October 25 th , 2007 (22)

10.50		Robotic Workspace Technologies, Inc. Patent and Trademark Agreement, dated October 25 th , 2007 (22)

10.51		Form of Series C Convertible Preferred Stock Subscription Agreement, dated October 13, 2007 (22)

10.52		Form of Warrant, dated October 13, 2007 (22)

10.53		Certificate of Designation (22)

10.54		Employment Termination and Retirement Agreement, dated December 18, 2007 (21)

10.55		Consulting Agreement, dated December 18, 2007 (21)

10.56		Securities Purchase Agreement, dated March 20 th , 2008 (23)

10.57		Secured Convertible Debenture, dated March 20 th , 2008 (23)

10.58		Warrant, dated March 20 th , 2008 (23)

10.59		Registration Rights Agreement, dated March 20 th , 2008 (23)

10.60		Security Agreement, dated November 2 nd , 2007 (23)

10.61		Patent and Trademark Security Agreement, dated October 29 th , 2007 (23)

10.62		Amendment Agreement, dated March 20 th , 2008 (23)

10.63		Amendment to Articles of Incorporation dated April 23, 2008

10.64		2008 Incentive Stock Plan

10.65		Amended 2008 Incentive Stock Plan

10.66		Amendment to Articles of Incorporation dated January 23, 2009

10.67		Joint Venture Agreement

14.1		Code of Ethics

21.1		List of Subsidiaries *

31		Rule 13(a) -14(a)/15d-14(a) Certification of Principal Executive Officer and Principal Financial Officer*

32		Section 1350 Certification of Chief Executive Officer and Principal Financial Officer*

* Filed herewith

(1)	Incorporated by reference to the Form 8-K filed on February 4, 2003.

(2)	Incorporated by reference to the Form SB-2 filed on August 7, 2001.

(3)	Incorporated by reference to the Form 10-KSB filed on April 24, 2003.

(4)	Incorporated by reference to the Form 8-K filed on May 13, 2003.

(5)	Incorporated by reference to the Form 8-K filed on August 8, 2004.

(6)	Incorporated by reference to the Form 14C filed on June 30, 2004.

(7)	Incorporated by reference to the Form 8-K filed on September 28, 2004.

(8)	Incorporated by reference to the Form 8-K filed on January 11, 2005.

(9)	Incorporated by reference to the Form 10-KSB filed on April 19, 2005.

(10)	Incorporated by reference to the Form 8-K filed on June 16, 2005.

(11)	Incorporated by reference to the Form 8-K filed on October 19, 2006.

(12)	Incorporated by reference to the Form 8-K filed on July 6, 2005.

(13)	Incorporated by reference to the Form 8-K filed on January 27, 2006.

(14)	Incorporated by reference to the Form 10-KSB filed on April 19, 2006.

(15)	Incorporated by reference to Amendment 1 to the Schedule 14A filed on July 31, 2006.

(16)	Incorporated by reference to the Form 8-K filed on July 25, 2006.

(17)	Incorporated by reference to the Form 8-K filed on June 22, 2006.

(18)	Incorporated by reference to the Form 8-K filed on May 22, 2006.

(19)	Incorporated by reference to the Form 8-K filed on May 3, 2006.

(20)	Incorporated by reference to the Registration Statement on Form SB-2 filed on November 9, 2007.

(21)	Incorporated by reference to the Form 8-K filed on December 26, 2007.

(22)	Incorporated by reference to the Registration Statement on Form S-1 filed on February 13, 2008

(23)	Incorporated by reference to the Form 8-K filed on March 26, 2008.

(24)	Incorporated by reference to the Form 10-KSB filed April 15, 2008

(25)	Incorporated by reference to the Form 8-K filed on May 14, 2008.

(26)	Incorporated by reference to the Form 10-Q filed on May 20, 2008.

(27)	Incorporated by reference to the Form S-8 filed on May 29, 2008.

(28)	Incorporated by reference to the Form S-8 filed on July 30, 2008.

(29)	Incorporated by reference to the Form 10-Q filed on August 19, 2008.

(30)	Incorporated by reference to the Form 8-K filed on November 19, 2008.

(31)	Incorporated by reference to the Form 10-Q filed on November 19, 2008.

(32)	Incorporated by reference to the Form 8-K filed on March 18, 2009.

(33)	Incorporated by reference to the Form 8-K filed on April 7, 2009.

(34)	Incorporated by reference to the Form 5 filed on May 12, 2009.

(35)	Incorporated by reference to the Form 10-K filed on May 18, 2009.

(36)	Incorporated by reference to the Form 10Q filed on May 20, 2009.

(37)	Incorporated by reference to the Form 8-K filed on August 7, 2009.

(38)	Incorporated by reference to the Form 10Q filed on August 19, 2009.

(39)	Incorporated by reference to the Form 8-K filed on August 28, 2009.

(40)	Incorporated by reference to the Form 8-K filed on October 22, 2009.

(41)	Incorporated by reference to the Form 10Q filed on November 23, 2009.

(42)	Incorporated by reference to the Form S-8 filed on December 16, 2009.

(43)	Incorporated by reference to the Form 8-K filed on January 10, 2010.

(44)	Incorporated by reference to the Form S-8 filed on March 29, 2010.

(45)	Incorporated by reference to the Form 10K filed on May 12, 2010.

(46)	Incorporated by reference to the Form 10Q filed on May 24, 2010.

(47)	Incorporated by reference to the Form 10Q filed on August 23, 2010.

(48)	Incorporated by reference to the Form 8K filed on September 17, 2010.

(49)	Incorporated by reference to the Form 10Q filed on November 22, 2010.

(50)	Incorporated by reference to the Form SC 13G filed on December 2, 2010.

(51)	Incorporated by reference to the Form S-8 filed on December 21, 2010.

(52)	Incorporated by reference to the Form 10K/A filed on January 5, 2012.

(53)	Incorporated by reference to the Form S-8 POS filed on February 22, 2012.

(54)	Incorporated by reference to the Form 8K filed on March 16, 2012.

(55)	Incorporated by reference to the Form NT 10-K filed on March 30, 2012.

(56)	Incorporated by reference to the Form 8K filed on April 14, 2012.

(57)	Incorporated by reference to the Form 10K filed on April 15, 2012.

(58)	Incorporated by reference to the Form NT 10-Q filed on May 16, 2012.

(59)	Incorporated by reference to the Form 10-Q filed on June 6, 2012.

(60)	Incorporated by reference to the Form Pre 14C filed on June 24, 2012.

(61)	Incorporated by reference to the Form Def 14A filed on July 29, 2012.

(62)	Incorporated by reference to the Form NT 10-Q filed on August 15, 2012.

(63)	Incorporated by reference to the Form Defr 14A filed on August 18, 2012.

(64)	Incorporated by reference to the Form 10-Q filed on August 19, 2012.

(65)	Incorporated by reference to the Form 10-Q/A filed on September 22, 2012.

(66)	Incorporated by reference to the Form 8K filed on September 23, 2012.

(67)	Incorporated by reference to the Form 3 filed on October 3, 2012.

(68)	Incorporated by reference to the Form 4 filed on October 3, 2012.

(69)	Incorporated by reference to the Form 8K filed on November 9, 2012.

(70)	Incorporated by reference to the Form 8KA filed on November 14, 2012.

(71)	Incorporated by reference to the Form NT 10-Q filed on November 14, 2012.

(72)	Incorporated by reference to the Form 8K filed on November 16, 2012.

(73)	Incorporated by reference to the Form Pre 14C filed on November 16, 2012.

(74)	Incorporated by reference to the Form 10-Q filed on November 21, 2012.

(78)	Incorporated by reference to the Form 8K/A filed December 12, 2012.

(79)	Incorporated by reference to the Form 8K/A filed on December 12, 2012.

(80)	Incorporated by reference to the Form Pre 14C filed on December 12, 2012.

(81)	Incorporated by reference to the Form Def 14C filed on December 12, 2012

(82)	Incorporated by reference to the Form 8K/A filed on December 13, 2012.

(83)	Incorporated by reference to the Form S-8 filed on March 7, 2012.

(84)	Incorporated by reference to the Form 8-K filed on March 7, 2012.

(85)	Incorporated by reference to the Form NT-10K filed on March 30, 2012.

(86)	Incorporated by reference to the Form 10K filed on April 16, 2012.

(87)	Incorporated by reference to the Form 10-K/A filed on April 18, 2012.

(88)	Incorporated by reference to the Form 10-K/A filed on April 25, 2012.

(89)	Incorporated by reference to the Form Pre 14C filed on May 4, 2012.

(90)	Incorporated by reference to the Form 10-Q filed on May 21, 2012.

(91)	Incorporated by reference to the Form Pre 14C filed on June 11, 2012.

(92)	Incorporated by reference to the Form Def 14C filed on June 15, 2012.

(93)	Incorporated by reference to the Form 8-K filed on July 11, 2012.

(94)	Incorporated by reference to the Form NT 10-Q filed on August 14, 2012.

(95)	Incorporated by reference to the Form 10-Q filed on August 20, 2012.

(96)	Incorporated by reference to the Form S-8 filed on August 23, 2012.

(97)	Incorporated by reference to the Form 3 filed on October 1, 2012.

(98)	Incorporated by reference to the Form 8-K filed on October 3, 2012.

(99)	Incorporated by reference to the Form S-8 filed on October 30, 2012.

(100)	Incorporated by reference to the Form NT 10-Q filed on November 13, 2012.

(101)	Incorporated by reference to the Form 10-Q filed on November 19, 2012.

(102)	Incorporated by reference to the Form S-8 filed on January 28, 2013.

(103)	Incorporated by reference to the Form 10-Q/A filed on January 31, 2013.

(104)	Incorporated by reference to the Form 10-Q/A filed on January 31, 2013.

(105)	Incorporated by reference to the Form 10-K/A filed on January 31, 2013.

(106)	Incorporated by reference to the Form Pre 14C filed on February 28, 2013

(107)	Incorporated by reference to the Form 5 filed on March 5, 2013.

(108)	Incorporated by reference to the Form 4 filed on March 5, 2013.

(109)	Incorporated by reference to the Form Def 14C filed on March 25, 2013.

(110)	Incorporated by reference to the Form 8-K filed on April 15, 2013.

(111)	Incorporated by reference to the Form 10K/A filed on May 23, 2013.

(112)	Incorporated by reference to the Form 10-Q filed on June 4, 2013.

(113)	Incorporated by reference to the Form 10-Q/As filed on June 18, 2013.

(114)	Incorporated by reference to the Form 10-Q/A filed on June 19, 2013.

(115)	Incorporated by reference to the Form 10-Q filed on August 19, 2013.

(116)	Incorporated by reference to the Form 8-K/A filed on August 20, 2013.

(117)	Incorporated by reference to the Form 8-K filed on August 22, 2013.

(118)	Incorporated by reference to the Form 8-K/A filed on August 28, 2013.

(119)	Incorporated by reference to the Form 8-K filed on October 10, 2013.

(120)	Incorporated by reference to the Form 10-Q filed on November 19, 2013.

(121)	Incorporated by reference to the Form Def 14C filed on November 25, 2013.

(122)	Incorporated by reference to the Form 8-K filed on December 13, 2013.

(123)	Incorporated by reference to the Form 8-K/A filed on December 24, 2013.

(124)	Incorporated by reference to the Form 10-Q/A filed on January 9, 2014.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: October 3, 2014

	COROWARE, INC.

	By:	/s/ Lloyd T. Spencer
		Lloyd T. Spencer
		Chief Executive Officer and Interim Chief Financial Officer (Principal Executive Officer and Principal Accounting and Financial Officer)

In accordance with the Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date

/s/ Lloyd T. Spencer
Lloyd T. Spencer	Chief Executive Officer and Interim Chief Financial Officer, Chairman of the Board of Directors (Principal Executive Officer and Principal Accounting and Financial Officer),	October 3, 2014

Index to Financial Statements

	Page
Report of Independent Registered Public Accounting Firm		F-2

Consolidated Balance Sheets as of December 31, 2013 and December 31, 2012		F-3

Consolidated Statements of Operations for the Years Ended December 31, 2013 and December 31, 2012		F-5

Consolidated Statements of Stockholders' Deficit for the Years Ended December 31, 2013 and December 31, 2012		F-6

Consolidated Statements of Cash Flows for the Years Ended December 31, 2013 and December 31, 2012		F-7

Notes to Consolidated Financial Statements		F-9 – F-31

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors

CoroWare, Inc.

We have audited the accompanying consolidated balance sheets of CoroWare, Inc. (the Company) as of December 31, 2013 and 2012 and the related consolidated statements of operations, stockholders’ deficit and cash flows for the years then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion the consolidated financial statements referred to above present fairly, in all material respects, the financial position of CoroWare, Inc. as of December 31, 2013 and 2012, and the results of their operations and cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company had accumulated losses for the period from inception through December 31, 2013 which raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Sadler, Gibb & Associates, LLC

Salt Lake City, UT

November 21, 2014

F-2

COROWARE, INC.
Consolidated Balance Sheets

	December 31,		December 31,
	2013		2012
			(Restated)
ASSETS

CURRENT ASSETS

Cash	$	-	$	2,754
Accounts receivable, net		-		90,636
Inventory, net		23,601		15,267
Other current assets		1,109		21,109
Total Current Assets		24,710		129,766

PROPERTY AND EQUIPMENT, net		12,820		15,453

OTHER ASSETS
Other assets, net		10,356		12,874
Total Other Assets		10,356		12,874

TOTAL ASSETS	$	47,886	$	158,093

The accompanying notes are an integral part of these consolidated financial statements.

F-3

COROWARE, INC.
Consolidated Balance Sheets (Continued)

	December 31,			December 31,
	2013			2012
				(Restated)

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
Accounts payable and accrued expenses	$	6,133,491		$	5,194,477
Accrued expenses- related parties		183,929			183,929
Obligations collateralized by receivables		149,637			117,722
Bank overdraft		1,635			-
Notes payable		515,082			504,832
Notes payable-related parties		218,275			207,612
Derivative liability		4,780,032			5,473,163
Current maturities of convertible debt, net of discount		2,452,430			2,265,487
Total Current Liabilities		14,434,511			13,947,222

LONG-TERM LIABILITIES
Small business administration loan		980,450			980,450
Convertible debentures, net of current maturities		-			49,090
Total Long-Term Liabilities		980,450			1,029,540

Total Liabilities		15,414,961			14,976,762

Commitments and contingencies		-			-

STOCKHOLDERS' DEFICIT
Convertible preferred stock, Series B, $0.001 par
value, 525,000 shares authorized, 159,666 shares
issued and outstanding		160			160
Convertible preferred stock, Series D, $0.001 par
value, 500,000 shares authorized, 100,000 shares
issued and outstanding		100			100
Convertible preferred stock, Series E, $0.001 par
value, 500,000 shares authorized, 339,559 and 40,000
shares issued and outstanding, respectively		340			40
Common stock; 13,000,000,000 shares authorized
at $0.0001 par value, 4,722,024,567 and 320,174,320
shares issued and outstanding, respectively		472,210			32,025
Additional paid-in capital		25,478,236			24,196,156
Non controlling interest		91,553			39,298
Treasury stock		(35,700	)		(35,700	)
Accumulated deficit		(41,373,974	)		(39,050,748	)
Total Stockholders' Deficit		(15,367,075	)		(14,818,669	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	47,886		$	158,093

The accompanying notes are an integral part of these consolidated financial statements.

F-4

COROWARE, INC.
Consolidated Statements of Operations

	For the Years Ended
	December 31,
	2013			2012
				(Restated)

REVENUES	$	1,067,229		$	1,276,022
COST OF SALES		761,413			851,385
GROSS PROFIT		305,816			424,637

OPERATNG EXPENSES
General and administrative		1,439,421			425,446
Sales and marketing		212,371			291,961
Research and Development		23,415			58,948
Depreciation and amortization		3,000			12,000
Total Operating Expenses		1,678,207			788,355

LOSS FROM OPERATIONS		(1,372,391	)		(363,718	)

OTHER INCOME (EXPENSE)
Gain (loss) on derivative valuation		4,985,720			(2,597,552	)
Gain (loss) on convertible debt redemptions		-			(52,280	)
Interest expense		(5,909,300	)		(1,068,507	)
Gain on extinguishment of debt		-			71,069
Total Other Income (Expense)		(923,580	)		(3,647,270	)

INCOME (LOSS) BEFORE NON CONTROLLING INTEREST		(2,295,971	)		(4,010,988	)
Net income (loss) attributable to non controlling interest		(27,255	)		30,702

INCOME (LOSS) BEFORE INCOME TAXES		(2,323,226	)		(3,980,286	)

PROVISION FOR INCOME TAXEES		-			-

NET INCOME (LOSS)	$	(2,323,226	)	$	(3,980,286	)

PREFERRED DIVIDENDS		-			-

NET INCOME (LOSS) ATTRIBUTABLE
TO COMMON SHAREHOLDERS	$	(2,323,226	)	$	(3,980,286	)

BASIC AND DILUTED INCOME (LOSS) PER SHARE	$	(0.00	)	$	(0.06	)

WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING - BASIC AND DILUTED		3,467,095,318			65,843,849

The accompanying notes are an integral part of these consolidated financial statements.

F-5

COROWARE, INC.

Consolidated Statement of Stockholders' Deficit

(Restated)

																	Additional			Non
	Preferred Stock										Common Stock						Paid-In			Controlling			Treasury			Accumulated
	Series B		Series D		Series E			Amount			Shares			Amount			Capital			Interest			Stock			Deficit			Total

Balance, December 31, 2011		159,666		100,000		-		$	260			4,181,484		$	418		$	23,768,910		$	-		$	(35,700	)	$	(35,070,462	)	$	(11,336,574	)

Common stock issued for
services and compensation		-		-		-			-			63,678,079			6,375			79,031			-			-			-			85,406

Common stock issued
for convertible debt		-		-		-			-			214,314,757			21,432			262,655			-			-			-			284,087

Investment in joint venture		-		-		-			-			38,000,000			3,800			45,600			70,000			-			-			119,400

Preferred shares issued for
services rendered		-		-		40,000			40			-			-			39,960			-			-			-			40,000

Non-controlling interest		-		-		-			-			-			-			-			(30,702	)		-			-			(30,702	)

Net loss for year ended
December 31, 2012		-		-		-			-			-			-			-			-			-			(3,980,286	)		(3,980,286	)

Balance, December 31, 2012		159,666		100,000		40,000		$	300			320,174,320		$	32,025		$	24,196,156		$	39,298		$	(35,700	)	$	(39,050,748	)	$	(14,818,669	)

Preferred shares issued for
services rendered		-		-		320,000			320			-			-			298,951			-			-			-			299,271

Common stock issued
for convertible debt		-		-		-			-			4,098,220,260			409,823			975,949			-			-			-			1,385,772

Common stock issued for
services and compensation		-		-		-			-			119,429,987			11,942			25,580			-			-			-			37,522

Cancellation of common shares		-		-		-			-			(102,000,000	)		(10,200	)		10,200			-			-			-			-

Common shares issued
in conversion of Series E
preferred stock		-		-		(20,441	)		(20	)		286,200,000			28,620			(28,600	)		-			-			-			-

Non-controlling interest		-		-		-			-			-			-			-			52,255			-			-			52,255

Net loss for year ended
December 31, 2013		-		-		-			-			-			-			-			-			-			(2,323,226	)		(2,323,226	)

Balance, December 31, 2013		159,666		100,000		339,559		$	600			4,722,024,567		$	472,210		$	25,478,236		$	91,553		$	(35,700	)	$	(41,373,974	)	$	(15,367,075	)

The accompanying notes are an integral part of these consolidated financial statements.

F-6

COROWARE, INC.
Consolidated Statements of Cash Flows

	For the Years Ended
	December 31,
	2013			2012
				(Restated)
OPERATING ACTIVITIES
Net loss	$	(2,323,226	)	$	(3,980,286	)
Net loss attributable to non-controlling interests		52,255			30,702
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization		3,000			12,001
Debt discount amortization		454,329			172,555
Bad debt expense		-			30,000
Preferred stock issued for services		299,271			40,000
Common stock issued for services		37,522			86,968
Gain on settlement of debt		-			(52,280	)
Excess derivative		4,710,125			453,605
(Gain) loss on remeasurement of derivative liability		(4,985,720	)		2,597,552
Changes in operating assets and liabilities:
Bank overdraft		1,635			-
Accounts receivable		90,636			8,802
Other current assets		-			(13,591	)
Deposits and other assets		20,000			-
Inventory		(8,334	)		(11,484	)
Accounts payable and accrued expenses		1,211,372			501,748
Accounts payable and accrued - related parties		-			72,463
Other assets		2,517			(5,946	)
Net Cash Used in Operating Activities		(434,618	)		(57,191	)

INVESTING ACTIVITIES
Purchase of property and equipment		(367	)		(3,121	)
Net Cash Used in Investing Activities		(367	)		(3,121	)

FINANCING ACTIVITIES
Obligations collateralized by receivables		31,915			9,992
Proceeds from related party loans		13,793			10,900
Payments on related party loans		(3,130	)		(12,201	)
Proceeds from convertible debt financings		495,413			219,475
Payments on convertible debt		(116,010	)		(168,222	)
Payments on notes payable		-			(3,400	)
Proceeds from notes payable		10,250			6,000
Net Cash Provided by Financing Activities		432,231			62,544

NET INCREASE (DECREASE) IN CASH		(2,754	)		2,232
CASH AT BEGINNING OF PERIOD		2,754			522

CASH AT END OF PERIOD	$	-		$	2,754

The accompanying notes are an integral part of these consolidated financial statements.

F-7

COROWARE, INC.

Consolidated Statements of Cash Flows (Continued)

	For the Years Ended
	December 31,
	2013		2012
			(Restated)
SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION

CASH PAID FOR:
Interest	$	-	$	-
Income taxes	$	-	$	-

NON CASH FINANCING ACTIVITIES:
Debt discounts on derivative liability	$	459,656	$	209,287
Common stock issued upon conversion of debt	$	1,395,972	$	392,761
Conversion of Preferred E stock in to common stock	$	28,620	$	-

The accompanying notes are an integral part of these consolidated financial statements.

F-8

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

CoroWare, Inc ("CoroWare" or "the Company") is a public holding company whose principal subsidiary, CoroWare Technologies, Inc. ("CTI"), has expertise in information technology consulting, mobile robotics, and affordable collaboration. Through its subsidiary, the Company delivers custom engineering services, hardware and software products, and subscription services that benefit customers in North America, Europe, Australia, Asia and the Middle East. Their customers span multiple industry sectors and comprise universities, software and hardware product development companies, and non-profit organizations. The company also maintains a Near Shore practice which is comprised of multiple subcontracting companies with whom the company maintains close working relationships. Through these relationships, the Company is able to provide services in South America.

CTI is a software professional services company with a strong focus on Information Technology integration and robotics integration, business automation solutions, and unmanned systems solutions to its customers in North America and Europe. CTI’s expertise includes the deployment and integration of computing platforms and applications, as well as the development of unmanned vehicle software and solutions for customers in the research, commercial, and homeland security market segments. CTI shall continue to offer its high value software systems development and integration services that complement the growing trend in outsourced software development services in Asia, Latin America, and Eastern Europe.

CTI comprises three separately managed lines of business:

§	CoroWare Business Solutions: IT and lab management; business intelligence, software architecture, design and development; content delivery; partner and program management.

§	Robotics and Automation: Custom engineering such as visualization, simulation and software development; and mobile robot platforms for university, government and corporate researchers.

§	Enhanced Collaboration Solutions: Collaboration and conferencing products, solutions and subscription services.

NOTE 2 – GOING CONCERN

The Company incurred a net loss in the amount of $2,323,226 during the year ended December 31, 2013 and incurred a net loss of $3,980,286 for the year ended December 31, 2012. The Company has negative working capital of $14,409,801 and $13,817,456 as of December 31, 2013 and 2012, respectively. Additionally, the Company had negative cash flows from operating activities totaling $434,618 and $57,191 for the years ended December 31, 2013 and 2012, respectively. Because of these and other factors, the Company will require additional working capital to develop its business operations. The Company intends to raise additional working capital through the use of private placements, public offerings and/or bank financing.

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placements, public offerings and/or bank financing necessary to support the Company's working capital requirements. To the extent that funds generated from operations, any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company.

F-9

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 2 – GOING CONCERN (CONTINUED)

These conditions raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CoroWare Technologies, Inc. (“CTI”), Innova Robotics, Inc. (“IR”), Robotic Workspace Technologies, Inc. (“RWT”), and Robotics Software Services, Inc. (“RSS”) (herein are referred to as the “Subsidiaries”). The Company also consolidates its 51 percent interest in ARiCON, LLC. All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company uses all available information and appropriate techniques to develop its estimates. However, actual results could differ from its estimates.

Cash and Cash Equivalents

Cash and cash equivalents include cash and all highly liquid financial instruments with original purchased maturities of three months or less.

Accounts Receivable

The Company’s accounts receivable are exposed to credit risk. During the normal course of business, the Company extends unsecured credit to its customers with normal and traditional trade terms. Typically credit terms require payments to be made by the thirtieth day following the sale. The Company regularly evaluates and monitors the creditworthiness of each customer. The Company provides an allowance for doubtful accounts based on our continuing evaluation of its customers’ credit risk and its overall collection history. At December 31, 2012 the Company recorded an allowance for doubtful accounts in the amount of $30,000. The Company had an allowance balance of $27,873 at December 31, 2013.

Inventory

Inventories, which are comprised solely of finished goods, are stated at the lower of cost (based on the first-in, first-out method) or market. The Company provides for estimated losses from obsolete or slow-moving inventories, and writes down the cost of inventory at the time such determinations are made. Reserves are estimated based upon inventory on hand, historical sales activity, industry trends, the business environment and the expected net realizable value. The net realizable value is determined based upon current awareness of market prices.

F-10

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Property and Equipment

Property and equipment are recorded at cost. Expenditures for major renewals and improvements are capitalized while expenditures for minor replacements, maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Upon retirement or disposal of assets, the accounts are relieved of cost and accumulated depreciation and the related gain or loss, if any, is reflected in loss on disposal of assets in the consolidated statement of income and comprehensive income.

At least annually, the Company evaluates, and adjusts when necessary, the estimated useful lives. The changes in estimated useful lives did not have a material impact on depreciation in any period. The estimated useful lives are:

Leasehold improvements and buildings	3-20 years
Furniture and fixtures	4-10 years
Equipment	3-7 years

Impairment of Long-lived Assets

The Company evaluates the carrying value and recoverability of its long-lived assets when circumstances warrant such evaluation by applying the provisions of FASB ASC 360-35, Property, Plant and Equipment, Subsequent Measurement. FASB ASC 360-35 requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Additionally, taxes are calculated and expensed in accordance with applicable tax code.

Segment Reporting

ASC 280-10 defines operating segments as components of a company about which separate financial information is available that is evaluated regularly by the chief decision maker in deciding how to allocate resources and in assessing performance. The Company reports according to one main segment.

Fair Value Measurements

The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities

Level 2: Observable market-based inputs or inputs that are corroborated by market data

Level 3: Unobservable inputs that are not corroborated by market data

F-11

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Stock-based Compensation

Stock-based compensation expense is recorded in accordance with FASB ASC 718, Compensation – Stock Compensation, for stock and stock options awarded in return for services rendered. The expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest. There were no options granted during the years ending December 31, 2013 and 2012.

Revenue Recognition

The Company derives its software system integration services revenue from short-duration, time and material contracts. Generally, such contracts provide for an hourly-rate and a stipulated maximum fee. Revenue is recorded only on executed arrangements as time is incurred on the project and as materials, which are insignificant to the total contract value, are expended. Revenue is not recognized in cases where customer acceptance of the work product is necessary, unless sufficient work has been performed to ascertain that the performance specifications are being met and the customer acknowledges that such performance specifications are being met. The Company periodically review contractual performance and estimate future performance requirements. Losses on contracts are recorded when estimable. No contractual losses were identified during the periods presented.

The Company recognizes revenue for its software and software professional services when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is probable. Product sales are recognized by us generally at the time product is shipped. Shipping and handling costs are included in cost of goods sold.

The Company accounts for arrangements that contain multiple elements in accordance with FASB ASC 605-25, Revenue Recognition, Multiple Element Arrangements. When elements such as hardware, software and consulting services are contained in a single arrangement, or in related arrangements with the same customer, the Company allocates revenue to each element based on its relative fair value, provided that such element meets the criteria for treatment as a separate unit of accounting. The price charged when the element is sold separately generally determines fair value. In the absence of fair value for a delivered element, the Company allocates revenue first to the fair value of the underlying elements and allocate the residual revenue to the delivered elements. In the absence of fair value for an undelivered element, the arrangement is accounted for as a single unit of accounting, resulting in a delay of revenue recognition for the delivered elements until the undelivered elements are fulfilled.

The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on future delivery of products or services or subject to customer-specified return of refund privileges. The Company recognizes revenue from the sale of manufacturer’s maintenance and extended warranty contracts in accordance with FASB ASC 605-45, Revenue Recognition, Principal Agent Considerations, net of its costs of purchasing the related contracts.

The Company’s collaboration revenue is comprised of both services and products. Collaboration service revenues are generated through the sale of CoroCall™, a managed collaboration service. Our contracts provide for usage pricing or when paid for pre-paid service. The Company recognizes this revenue in the period that the services or minutes are used and prepaid. Product revenues are realized partly through the sale of Vidyo’s product line, including room systems and back-end infrastructure, and partly through the sale of CoroWare collaboration products, including CoroWare Usage Reporter for Vidyo, a software package that provides usage statistics for Vidyo brand high-definition video conferencing systems, and partly through sales of accessories. Revenues for these products are recognized when the product is delivered to the customer.

F-12

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Research and Development

Research and development costs relate to the development of new products, including significant improvements and refinements to existing products, and are expensed as incurred. Research and development expenses for the years ended December 31, 2013 and 2012 were $23,415 and $58,948, respectively.

Advertising Expense

The Company expenses advertising costs as they are incurred. Advertising expense for the years ending December 31, 2013 and 2012 were $21,184 and $33,969, respectively.

Concentration of Credit Risk

Financial instruments which potentially expose the Company to concentrations of credit risk are cash and cash equivalents and trade accounts receivable. The Company maintains its cash and cash equivalents in deposit accounts with high quality, credit-worthy financial institutions.

At December 31, 2012 and 2011, the Company’s revenues and receivables were comprised of the following customer concentrations:

	2013		2012
	Percent of Revenues	Percent of Receivables	Percent of Revenues	Percent of Receivables
Customer 1	64.41%	88.89%	56.75%	18.44%

Basic and Diluted Loss per Share

Basic loss per share is calculated by dividing the Company’s net loss applicable to shareholders by the weighted average number of shares outstanding during the period. Diluted loss per share is calculated by dividing the Company’s net loss available to shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is adjusted for any potentially dilutive debt or equity instruments. As of December 31, 2013 and 2012, there were 220,505,673 and 63,831,589 common stock equivalents outstanding, respectively, which were excluded from the calculation of diluted loss per unit as their effect would have been anti-dilutive.

Dividend Policy

F-13

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Recent Accounting Pronouncements

Management does not expect the impact of any other recently issued accounting pronouncements to have a material impact on its financial condition or results of operations.

NOTE 4 – ACCOUNTS RECEIVABLE FACTORING

On March 21, 2010, the Company established a $200,000 factoring line with an asset-based lender, CapeFirst Funding, LLC (“Capefirst”) that is secured by accounts receivable that the Lender may accept and purchase from the Company. The agreement calls for Capefirst to advance up to 80% of the net face amount of each assigned account or up to 50% of eligible assigned purchase orders. The agreement calls for a maximum facility amount of $200,000 with a purchase fee of 2% of the net face amount of each assigned account and a collection fee of 0.1% compounded daily. In the event of a dispute or in the event of fraud, misrepresentation, willful misconduct or negligence on the part of the Company, Capefirst may require the Company to immediately repurchase the assigned accounts at a purchase price that includes the amount of the assigned account plus the discount fee, interest and collection fee and may include a processing fee of 10%. The combined net balance due to Capefirst as of December 31, 2013 and 2012 was $149,638 and $117,722, respectively. Factor expense charged to operations for the years ended December 31, 2013 and 2012 amounted to $64,568 and $48,689, respectively.

The Company has adopted the FASB’s amended authoritative guidance which was issued in June 2009 and which became effective January 1, 2010 as it relates to distinguishing between transfers of financial assets that are sales from transfers that are secured borrowings. Under this new guidance as adopted by the Company effective January 1, 2010, the reporting of the sale of accounts receivable is treated as a secured borrowing rather than as a sale. As a result, affected accounts receivable are reported under Current Assets within the Company’s balance sheet as “Trade receivables” subject to reserves for doubtful accounts, returns and other allowances. Similarly, the net liability owing to Capefirst appears as “obligations collateralized by receivables” within the current liabilities section of the Company’s balance sheet. Net proceeds received from the sale of accounts receivable appear as cash provided or used by financing activities within the Company’s consolidated statements of cash flows. Early adoption of this amended guidance was not permitted. Under the authoritative guidance in effect prior to the amended guidance noted above, after a transfer of financial assets, an entity recognizes the financial and servicing assets it controls and liabilities it has incurred, derecognizes financial assets when control has been surrendered, and derecognizes liabilities when extinguished.

NOTE 5 – INVENTORY

As of December 31, 2013 and 2012, inventories consist of the following:

	December 31, 2013		December 31, 2012
Raw materials	$	-	$	-
Work in process		-		-
Finished goods		23,601		15,267
Subtotal		23,601		15,267
Less: inventory reserve		-		-
Inventory, net	$	23,601	$	15,267

F-14

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 6 – PROPERTY AND EQUIPMENT

Property and equipment consists of the following at December 31, 2013 and 2012:

	December 31, 2013			December 31, 2012
Computer equipment	$	85,748		$	85,381
Furniture and fixtures		7,862			7,862
Subtotal		96,610			93,243
Less: accumulated depreciation		(80,790	)		(77,790	)
Property and equipment, net	$	12,820		$	15,453

Depreciation expense for the years ended December 31, 2013 and 2012 was $3,000 and $12,000, respectively.

NOTE 7 – INVESTMENT IN JOINT VENTURE

On September 27, 2012, the Company partnered with a private investor to launch a joint venture – ARiCON, LLC to develop and market mobile robot platforms, applications, and solutions for the construction industry.

The joint venture is currently comprised of CoroWare (51% ownership), who agreed to contribute 38,000,000 shares of restricted CoroWare common stock, (1) mobile robot for prototype development, $10,000 cash, and mobile robotics development expertise; and Lucas Snyder (49% ownership), a private investor who agreed to contribute $50,000 cash, construction industry expertise, and customer relationships.

Through its combined expertise in construction and robotics, ARiCON intends to address the growing need for Computer Aided Production (CAP) solutions, with its initial focus on the development of robotic layout systems.

NOTE 8 – LINES OF CREDIT

The Company has numerous unsecured lines of credit with various financial institutions bearing annual interest at rates ranging from 4.75% to 36.00%. At December 31, 2013 and 2012 the company had aggregate outstanding balances on these lines of $122,305 and $125,435, respectively. These lines of credit have no collateral and are payable monthly.

NOTE 9 – NOTES PAYABLE

Notes payable consist of the following at December 31, 2013 and 2012:

			December 31, 2013				December 31, 2012
			Related Parties		Other		Related Parties		Other
Notes payable – Merger	9(a)	$	-	$	100,000	$	-	$	100,000
Notes payable – Shareholders	9(b), 10		218,275		-		207,612		-
Note payable – Third parties	9(c)		-		45,000		-		45,000
Notes payable – Yorkville	9(d)		-		337,500		-		337,500
Other notes payable	9(e)		-		32,582		-		22,332
Total		$	218,275	$	515,082	$	207,612	$	504,832

F-15

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 9 – NOTES PAYABLE (CONTINUED)

(a) Notes payable - Merger:

(b) Notes payable - Shareholders:

(d) Other notes payable

NOTE 10 – NOTES PAYABLE, RELATED PARTIES

As of December 31, 2013 and 2012 the Company had an aggregate total of $218,275 and $207,612, respectively, in notes payable. These notes bear interest at rates ranging from zero percent per annum to 18 percent per annum. As of December 31, 2013 all notes payable to related parties were in default. Accrued interest on notes payable totaled $154,869 and $118,123 at December 31, 2013 and 2012, respectively.

F-16

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 11 – SMALL BUSINESS ADMINISTRATION LOAN

On April 17, 2002, the Company borrowed $989,100 under a note agreement with the Small Business Administration. The note bears interest at 4% and is secured by the equipment and machinery assets of the Company. The balance outstanding at December 31, 2013 and 2012 was $980,450. The note calls for monthly installments of principal and interest of $4,813 beginning September 17, 2002 and continuing until April 17, 2032.

The Company and the Small Business Administration reached an agreement in November 2010 whereby the Small Business Administration would accept $500 per month for 12 months with payment reverting back to $4,813 in November 2011. The Company only made four payments under the modification agreement. The Company continues to carry the loan as a current term liability because current payments are not being made, resulting in a default. Accrued interest payable on the note totaled $227,860 and $188,320 as of December 31, 2013 and 2012, respectively.

NOTE 12 – CONVERTIBLE NOTES PAYABLE

The following table illustrates the carrying value of convertible debt at December 31, 2013 and 2012:

		Note Principal Balance
		December 31,
Lender Name	Reference	2013		2012
AGS Capital Group, LLC	12(a)	$	157,687	$	-
Asher Enterprises, Inc.	12(b)		102,795		61,275
Barclay Lyons, LLC	12(c)		10,750		10,750
Blackbridge Capital, LLC	12(d)		52,042		67,042
Cariou, Raphael	12(e)		31,838		61,838
Collins, Thomas	12(f)		39,170		39,170
Kellburgh, Ltd.	12(g)		13,000		13,000
Magna Group, LLC	12(h)		-		10,000
Panache Capital, LLC	12(i)		32,685		54,881
Premier I.T. Solutions Corp.	12(j)		21,962		21,962
Ratzker, David	12(k)		39,184		152,007
Redwood Management, LLC	12(l)		169,647		204,897
Ridgepoint Capital	12(m)		63,715		49,090
Sobeck, Michael	12(n)		14,538		28,500
Tangiers Investment Group, LLC	12(o)		62,891		-
Tangiers Investors, L.P.	12(p)		-		24,669
Westmount International Holdings	12(q)		537,318		540,581
Y.A. Global Investments, L.P	12(r)		1,065,433		1,071,543
Zoom Marketing Corporation	12(s)		140,000		-
Total Convertible Notes Payable		$	2,554,656	$	2,411,206

Less: Current Portion			2,554,656		2,362,116
Long-Term Convertible Notes Payable		$	-	$	49,090

In the Company’s evaluation of each convertible debt instrument in accordance with FASB ASC 815, Derivatives and Hedging (pre-codification FAS 133 “Accounting for Derivative Financial Instruments and Hedging Activities”), based on the variable conversion price, it was determined that the conversion features were not afforded the exemption as a conventional convertible instrument and did not otherwise meet the conditions for equity classification. As such, the conversion and other features were compounded into one instrument, bifurcated from the debt instrument and carried as a derivative liability, at fair value (see Note 13).

F-17

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 12 – CONVERTIBLE NOTES PAYABLE (CONTINUED)

(a) AGS Capital Group, LLC:

(b) Asher Enterprises, Inc.:

(d) Blackbridge Capital, LLC:

F-18

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 12 – CONVERTIBLE NOTES PAYABLE (CONTINUED)

(e) Cariou, Raphael:

(f) Collins, Thomas:

(g) Kellburgh, Ltd.:

(h) Magna Group, LLC:

(i) Panache Capital, LLC:

F-19

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 12 – CONVERTIBLE NOTES PAYABLE (CONTINUED)

(j) Premier I.T. Solutions Corp.:

(k) Ratzker, David:

(l) Redwood Management, LLC:

(m) Ridgepoint Capital:

(n) Sobeck, Michael:

F-20

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 12 – CONVERTIBLE NOTES PAYABLE (CONTINUED)

(o) Tangiers Investment Group, LLC:

(p) Tangiers Investors, LP:

(q) Westmount International Holdings:

(r) Y.A. Global Investments, LP:

F-21

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 12 – CONVERTIBLE NOTES PAYABLE (CONTINUED)

(s) Zoom Marketing Corporation:

NOTE 13 – DERIVATIVE LIABILITY

Effective July 31, 2009, the Company adopted ASC 815 which defines determining whether an instrument (or embedded feature) is solely indexed to an entity’s own stock. The conversion price of certain convertible notes and exercise price of certain warrants are variable and subject to the fair value of the Company’s units on the date of conversion or exercise. As a result, the Company has determined that the conversion and exercise features are not considered to be solely indexed to the Company’s own stock and is therefore not afforded equity treatment. In accordance with ASC 815, the Company has bifurcated the conversion and exercise features of the instruments to be recorded as a derivative liability.

ASC 815 requires Company management to assess the fair market value of certain derivatives at each reporting period and recognize any change in the fair market value as items of other income or expense. The Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with convertible notes payable and warrants.

At origination and subsequent revaluations, the Company valued the derivative liabilities using the Black-Scholes options pricing model under the following assumptions:

	2013			2012

Risk-free interest rate		1.37% - 1.75	%		0.02% - 0.79	%
Expected options life		3.55 - 5.00			0.33 - 5.00
Expected dividend yield		-			-
Expected price volatility		136.6% - 205.3	%		102.3% - 173.8	%

During the year ended December 31, 2012, the Company’s derivative liability increased from $2,463,271 to $5,473,163 and recognized a loss on derivative liability of$2,597,592 in conjunction with settlement of convertible notes payable, additions of new derivative liabilities andsubsequent revaluations of existing derivative liabilities.

During the year ended December 31, 2013, the Company’s derivative liability decreased from $5,473,163 to $4,780,032 and recognized a gain on derivative liability of $4,985,720 in conjunction with settlement of convertible notes payable, additions of new derivative liabilities and subsequent revaluations of existing derivative liabilities.

NOTE 14 – PREFERRED STOCK

a) Series A Preferred Stock

The Company has authorized 125,000 shares of Series A Preferred Stock. Each share of Series A Preferred Stock (i) pays a dividend of 5%, payable at the discretion of the Company in cash or common stock, (ii) is convertible immediately after issuance into the Company's common stock at the lesser of $0.005 per share or 75 percent of the average closing bid prices over the 20 trading days immediately preceding the date of conversion, (iii) has a liquidation preference of $1.00 per share, (iv) may be redeemed by the Company at any time up to five years after the issuance date for $1.30 per share plus accrued and unpaid dividends, and (v) has no voting rights except when mandated by Delaware law. There were no shares of Series A Preferred Shares outstanding at any time during the years ended December 31, 2013 and 2012.

F-22

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 14 – PREFERRED STOCK (CONTINUED)

b) Series B Preferred Stock

The Company has authorized 525,000 shares of Series B Preferred Stock. Each share of Series B Preferred Stock (i) pays a dividend of 5 percent, payable at the discretion of the Company in cash or common stock, (ii) is convertible immediately after issuance into the Company's common stock at the lesser of $15 per share or 75 percent of the average closing bid prices over the 20 trading days immediately preceding the date of conversion, (iii) has a liquidation preference of $1.00 per share, and (iv) may be redeemed by the Company at any time up to five years.

Based upon the Company’s evaluation of the terms and conditions of the Series B Preferred Stock, the embedded conversion feature related to the preferred stock was afforded the exemption as a conventional convertible instrument due to certain variabilities in the conversion price, and met the conditions for equity classification. However, the Company is required to bifurcate the embedded conversion feature and carry it as a derivative liability.

The Company estimated the fair value of the compound derivative using a common stock equivalent and the current share price of the Company’s common stock. As a result of this estimate, the Company’s valuation model resulted in a compound derivative balance associated with the Series B preferred stock of $233,333 and $250,980 as of December 31, 2013 and 2012, respectively. This amount is included as a current liability on the Company’s balance sheet. Fair value adjustments of $(37,647) and $113,346 were charged to derivative income (expense) for the years ended December 31, 2013 and 2012, respectively. At December 31, 2013 and 2012 the Company has 159,666 shares of series B preferred stock issued and outstanding.

c) Series C Preferred Stock

The Company has authorized 500,000 shares of Series C Preferred Stock. During 2007, the Company initiated a private offering under Regulation D of the Securities Act of 1933 (the “Private Offering”), of an aggregate 500,000 units (collectively referred to as the “Units”) at a price of $1.00 (one dollar) per unit, with each unit consisting of one share of Series C Convertible Preferred Stock at the lesser of eighty five percent (85%) of the average closing bid price of the Common Stock over the twenty (20) trading days immediately preceding the date of conversion or $0.04 and stock purchase warrants equal to the number of shares of common stock converted from the Series C Convertible Preferred Stock, exercisable at $0.06 per share and which expire five (5) years from the conversion date.

d) Series D Preferred Stock

On November 10, 2011 the Board approved by unanimous written consent an amendment to the Corporation’s Certificate of Incorporation to designate the rights and preferences of Series D Preferred Stock. There are 500,000 shares of Series D Preferred Stock authorized with a par value of $0.001. Each share of Series D Preferred Stock has a stated value equal to $1.00. These preferred shares rank higher than all other securities. Each outstanding share of Series D Preferred Stock shall be convertible into the number of shares of the Corporation’s common stock determined by dividing the Stated Value by the Conversion Price which is defined as eighty five percent (85%) of the average closing bid price of the Common Stock over the twenty (20) trading days immediately preceding the date of conversion, (ii) but no less than Par Value of the Common Stock. Mandatory conversion can be demanded by the Company prior to October 1, 2013. Each one share of the Series D Preferred Stock shall have voting rights equal to 100,000 votes of Common Stock.

There were no issuances, conversions or redemptions of Series D stock during the years ended December 31, 2013 and 2012. At December 31, 2013 and 2012 there were 100,000 shares of series D preferred stock issued and outstanding.

F-23

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 14 – PREFERRED STOCK (CONTINUED)

d) Series D Preferred Stock (Continued)

The Company estimated the fair value of the compound derivative using a common stock equivalent and the current share price of the Company’s common stock. As a result of this estimate, the Company’s valuation model resulted in a compound derivative balance associated with the Series D preferred stock of $89,295 and $105,053 as of December 31, 2013 and 2012, respectively. This amount is included as a current liability on the Company’s balance sheet. Fair value adjustments of $(15,758) and $47,443 were charged to derivative income (expense) for the year ended December 31, 2013 and 2012, respectively.

e) Series E Preferred Stock

On March 9, 2012, the Corporation filed the Certificate of Designation of the Rights and Preferences of Series E Convertible Preferred Stock of the Company with the Delaware Secretary of the State pursuant to which the Company set forth the designation, powers, rights, privileges, preferences and restrictions of 1,000,000 authorized shares of Series E Convertible Preferred Stock, par value $0.001 per share. The Series E preferred shares are convertible into common shares at 50% of the lowest closing bid price of the common stock over the twenty days immediately prior the date of conversion, but no less than the par value of the common stock ($0.0001).

In November 2012, the Company entered into an agreement to sell 40,000 shares of Series E preferred stock for services valued of $40,000. The value of the preferred stock was based on the value of common stock into which the Series E preferred stock was convertible on the date of issuance.

In May 2013, the Company issued 75,000 shares of Series E preferred stock for services valued at $15,000. In September, 2013 the Company issued 145,000 shares of Series E preferred stock for services valued at $29,000. The value of the preferred stock was based on the value of common stock into which the Series E preferred stock was convertible on the date of issuance. In addition, 20,441 shares of series E preferred stock were converted into 286,200,000 shares of common stock pursuant to the terms of the Series E preferred stock. At December 31, 2013 and 2012, the Company had 339,559 and 40,000 shares of Series E preferred stock issued and outstanding, respectively.

There were no conversions or redemptions of Series E stock during the years ended December 31, 2012.

f) Series F Preferred Stock

On October 4, 2013, the Company filed the certificate of designation pursuant to which the Company set forth the designation, powers, rights, privileges, preferences and restrictions of 500,000 authorized shares of Series F Convertible Preferred Stock, par value $0.001 per share.

The shares of preferred stock have a stated value of $1.00, have no voting rights, are entitled to no dividends due or payable and are convertible into the number of shares of the Corporation’s common stock determined by dividing the stated value by the conversion price which is defined as eighty five percent (85%) of the average closing bid price of the common stock over the five (5) trading days immediately preceding the date of conversion, but no less than par value of the common stock. At any time after the issuance date through the fifth (5th) anniversary of the issuance of the preferred stock, the Company shall have the option to redeem any unconverted shares at an amount equal to one hundred thirty percent (130%) of the stated value of the stock plus accrued and unpaid dividends, if any. Redemption shall be established by the Company in its sole and absolute discretion and no holder of Series F Preferred Stock may demand that the Series F Preferred Stock be redeemed.

No shares of Series F Preferred Stock were issued or outstanding as of December 31, 2013 and 2012.

F-24

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 15 – COMMON STOCK

The Company is authorized to issue up to 13,000,000,000 shares of $0.0001 par value common stock, of which 4,722,113,672 and 320,263,425 shares were issued and outstanding as of December 31, 2013 and 2012, respectively.

On July 6, 2012, the Company effected a one-for-two hundred (1:200) reverse split of the Company’s common stock. All common share amounts within this document have been adjusted to reflect this change.

During the year ended December 31, 2012, the Company issued 63,768,079 shares of common stock for services and compensation, resulting in a total value of $85,406. Additionally, the Company issued 214,314,757 shares of common stock pursuant to conversions of various notes payable and other debts. The shares were valued at an aggregate of $284,087. The Company issued an additional 38,000,000 shares as an investment in the ARiCON, LLC joint venture (see Note 7).

During the year ended December 31, 2013, the Company issued 119,429,987 shares of common stock for services and compensation, resulting in a total value of $37,522. Additionally, the Company issued 4,098,260 shares of common stock pursuant to conversions of various notes payable and other debts. The shares were valued at an aggregate of $1,385,772. The Company cancelled 102,000,000 shares of common stock and issued an additional 286,200,000 shares of common stock pursuant to the conversion of Series E preferred stock.

NOTE 16 – STOCK OPTIONS AND WARRANTS

Employee Stock Options

The Company has a 2005 Stock Option Plan which is authorized to issue 66,667 options. There are currently 38,164 options outstanding under this plan. Compensation cost of $20,134 was recognized during the years prior to December 31, 2012, for grants under the 2005 Stock Option Plan. During 2013 and 2012, -0- and -0- unvested options were forfeited by employees upon termination. No options were issued during 2013 or 2012.

Non-employee Stock Options

During 2008 there were 3,333 options granted to nonemployees to purchase shares of the Company’s common stock at $3. These options expire in ten years and vested immediately.

Stock Purchase Warrants

During the year ended December 31, 2010, the Company granted 5,000 warrants to acquire shares of common stock at $70.00 per share, 5,000 warrants to acquire shares of common stock at $90.00 per share and 5,000 warrants to acquire shares of common stock at $120.00 per share. All tranches of stock purchase warrants were issued to a single note holder in connection with the issuance of convertible debt.

During the year ended December 31, 2008, the Company granted 33,333 warrants to acquire shares of common stock at $1,200.00 per share to a note holder in connection with the issuance of convertible debt. At December 31, 2013 and 2012 there were 167 and -0- warrants outstanding. The options expired without exercise on March 19, 2013.

F-25

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 16 – STOCK OPTIONS AND WARRANTS (CONTINUED)

A summary of the status of the Company’s options and warrants as of December 31, 2013 and 2012 as well as the changes during the years ended December 31, 2013 and 2012 is presented below:

	Number of Options and Warrants

Outstanding at December 31, 2011		53,331

Options and warrants granted		-
Options and warrants exercised		-
Options and warrants forfeited or expired		-
Outstanding at December 31, 2012		53,331
Exercisable at December 31, 2012		53,331

Options and warrants granted		-
Options and warrants exercised		-
Options and warrants forfeited or expired		(167	)
Outstanding at December 31, 2013		53,164
Exercisable at December 31, 2013		53,164

In applying the Black-Scholes options pricing model to the option and warrant grants, the fair value of our share-based awards granted were estimated using the following assumptions for the periods indicated below:

Risk-free interest rate	0.10	%
Expected options life	4.00
Expected dividend yield	-
Expected price volatility	455.48	%

The following table summarizes information about stock options and warrants as of December 31, 2013:

	Options and Warrants Outstanding						Options and Warrants Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$1 to $69		38,164		2.37		$3.60		38,164		$3.60
$70 to $120		15,000		0.48		$93.33		15,000		$93.33
$121 to $1,200		-		-		-		-		-
		53,164		1.84		$28.92		53,164		$28.92

F-26

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 16 – STOCK OPTIONS AND WARRANTS (CONTINUED)

The following table summarizes information about stock options and warrants as of December 31, 2012:

	Options and Warrants Outstanding						Options and Warrants Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$1 to $69		38,164		3.37		$3.60		38,164		$3.60
$70 to $120		15,000		1.48		$93.33		15,000		$93.33
$121 to $1,200		167		1.25		$1,200.00		167		$1,200.00
		53,331		2.83		$32.58		53,331		$32.58

NOTE 17 – INCOME TAXES

The Company accounts for income taxes in accordance with ASC 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets at currently enacted tax rates for the expected future tax consequences of events that have been included in the financial statements or tax returns. A valuation allowance is recognized to reduce the net deferred tax asset to an amount that is more likely than not to be realized.

ASC 740 provides guidance on the accounting for uncertainty in income taxes recognized in a company’s financial statements. ASC 740 requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements.

Net deferred tax assets consist of the following components as of December 31, 2013 and 2012:

	For the Years Ended
	December 31,
	2013			2012
Current operations	$	789,877		$	1,353,297
Change in valuation allowance		(789,877	)		(1,353,297	)
Total provision for income taxes	$	-		$	-

The income tax provision differs from the amount of income tax determined by applying the estimated U.S. federal and state income tax rates of 34 percent to pretax income from continuing operations for the year ended December 31, 2013 and 2012 due to the following:

	December 31, 2013			December 31, 2012

Loss carryforwards (expire through 2033)	$	14,067,151		$	13,277,254
Valuation allowance		(14,067,151	)		(13,277,254	)
Net deferred taxes	$	-		$	-

F-27

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 17 – INCOME TAXES (CONTINUED)

At December 31, 2013, the Company had net operating loss carry forwards of approximately $6,303,512 through 2033. No tax benefit has been reported in the December 31, 2013 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

In accordance with generally accepted accounting principles, the Company has analyzed its filing positions in all jurisdictions where it is required to file income tax returns for the open tax years in such jurisdictions. The Company has identified its federal income tax returns for the previous five years remain subject to examination. The Company’s income tax returns in state income tax jurisdictions also remain subject to examination for the previous five years. The Company currently believes that all significant filing positions are highly certain and that all of its significant income tax filing positions and deductions would be sustained upon audit. Therefore, the Company has no significant reserves for uncertain tax positions, and no adjustments to such reserves were required by generally accepted accounting principles. No interest or penalties have been levied against the Company and none are anticipated, therefore no interest or penalty has been included in the provision for income taxes in the consolidated statements of operations.

NOTE 18 – COMMITMENTS

Lease Agreements

On August 1, 2011, the Company entered into a lease agreement on corporate offices located at 1410 Market Street, Kirkland, WA which terminated on December 23, 2013. Under this lease, the Company was obligated to pay an average monthly rent of $4,088 in 2012 and $4,233 in 2013. Since the termination of this lease, the Company has not signed a new lease for its corporate headquarters.

ARiCON, LLC Headquarters

Future minimum rentals on non-cancelable leases for the year ending December 31, 2013 are as follows:

2014	$	21,676
2015		16,050
2016		4,050
Thereafter		-
Total	$	41,776

F-28

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 19 – FAIR VALUE MEASUREMENTS

The company uses the Black-Sholes model to calculate the fair value of the derivative liability.

Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December 31, 2013 consisted of the following

				Fair Value Measurements Using
Description	Total Fair Value at December 31, 2013			Quoted Prices in Active Markets (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)

Derivative liability		$	4,780,032		$	-		$	4,780,032		-

Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of December 31, 2012 consisted of the following:

				Fair Value Measurements Using
Description	Total Fair Value at December 31, 2012			Quoted Prices in Active Markets (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)

Derivative liability		$	5,473,163		$	-		$	5,473,163		-

NOTE 20 – SUBSEQUENT EVENTS

Management has evaluated subsequent events according to the requirements of ASC Topic 855, and has determined that there were no material reportable subsequent events to be disclosed, other than those listed below:

Share Issuances on Convertible Debt

Subsequent to December 31, 2013, Company note holders elected to convert an aggregate of $1,327,831 in note principal and $395,854 in accrued interest into 3,700,150,043 shares of the Company’s common stock, pursuant to the respective conversion terms of the notes.

Subsequent to December 31, 2013, shareholders returned 102,000,000 shares to the treasury for cancellation.

Convertible Notes Payable

On February 21, 2014 the Company entered into a convertible note with an unrelated third party entity whereby the Company borrowed $40,000. The note accrues interest at a rate of five percent per annum, and is due on August 21, 2014. The note is convertible into the Company’s common stock at 60 percent of the lowest closing price during the 30-day period prior to conversion.

On February 21, 2014 the Company entered into a convertible note with an unrelated third party entity whereby the Company borrowed $5,000. The note accrues interest at a rate of eight percent per annum and is due on September 21, 2014. The note is convertible into shares of the Company's common stock at 60 percent of the lowest trading price during the 30-day period prior to conversion.

On March 27, 2014, 2014 the Company entered into a convertible note with an unrelated third party entity whereby the Company agreed to borrow $500,000. The note includes an original issue discount of $100,000; therefore, the note stipulates a total principal balance of $600,000. To date the Company has received $15,000 pursuant to the terms of the note. The note accrues no interest and is due on March 27, 2015. The note is convertible into shares of the Company's common stock at the lower of $0.001 or 50percent of the lowest trading price during the 20-day period prior to conversion.

On April 2, 2014 the Company entered into a convertible note with an unrelated third party entity whereby the Company borrowed $25,000. The note accrues interest at a rate of ten percent per annum and is due on October 1, 2014. The note is convertible into shares of the Company's common stock at the lesser of $0.01 and 60 percent of the lowest trading price during the 20-day period prior to conversion.

On April 2, 2014 the Company entered into a convertible note with an unrelated third party entity whereby the Company borrowed $25,000. The note accrues interest at a rate of ten percent per annum, and is due on October 1, 2014. The note is convertible into the Company’s common stock at the lesser of $0.01 per share and 60 percent of the lowest closing price during the 20-day period prior to conversion.

Preferred Stock

Series E Preferred Stock

Subsequent to December 31, 2013, the Company entered into a subscription agreements to sell 645,061 shares of Series E preferred stock for services. Also, 112,360 shares of Series E preferred stock were converted into 94,104,474 shares of common stock.

Series F Preferred Stock

Subsequent to December 31, 2013, the Company entered into a subscription agreements to sell 80,000 shares of Series F preferred stock for proceeds of $80,000 ($1.00 per share) to two company officers of 40,000 shares each.

F-29

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 20 – SUBSEQUENT EVENTS (CONTINUED)

Preferred Stock (Continued)

Series G Preferred Stock

On April 17, 2014, the Company filed the certificate of designation pursuant to which the Company set forth the designation, powers, rights, privileges, preferences and restrictions of 100,000 authorized shares of Series G Convertible Preferred Stock, par value $0.001 per share.

The shares of preferred stock have a stated value of $1.00, have voting rights equal to 5,000,000 votes of common stock, are entitled to no dividends due or payable, are non-redeemable and are convertible into the number of shares of the Corporation’s common stock determined by dividing the stated value by the conversion price which is defined as eighty five percent (85%) of the average closing bid price of the common stock over the twenty (20) trading days immediately preceding the date of conversion, but no less than par value of the common stock.

Subsequent to December 31, 2013, the Company issued 25,000 shares of Series G preferred stock to the Company’s chief executive officer in exchange for $25,000 of deferred salary ($1.00 per share).

NOTE 21 – RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS

The Company has restated the 2012 consolidated financial statements as originally presented in its amended Form 10-K filed on May 23, 2013. The changes and explanation of such are as follows:

As of December 31, 2012:

Consolidated Balance Sheet	Originally Reported		Restatement Adjustment				As Restated

Assets
Accounts receivable, net of allowance	$	176,123	$	(85,487	)	(a)	$	90,636

Liabilities
Accounts payable and accrued expenses		5,277,229		(82,752	)	(b)		5,194,477
Obligations collateralized by receivables		177,455		(59,733	)	(b)		117,722
Notes payable		232,332		272,500		(c)		504,832
Notes payable – related parties		202,612		5,000		(c)		207,612
Derivative liability		77,655,809		(72,182,646	)	(c)		5,473,163
Convertible debentures		2,480,635		(166,058	)	(c)		2,314,577
Redeemable preferred stock, Series B		70,961		(70,961	)	(d)		-
Redeemable preferred stock, Series D		34,602		(34,602	)	(d)		-
Redeemable preferred stock, Series E		50		(50	)	(d)		-

Stockholders’ Deficit
Redeemable preferred stock, Series B		-		160		(d)		160
Redeemable preferred stock, Series D		-		100		(d)		100
Redeemable preferred stock, Series E		-		40		(d)		40
Common stock		30,654		1,371		(c)		32,025
Additional paid-in capital		16,537,112		7,659,044		(c)		24,196,156
Accumulated deficit	$	103,623,848	$	64,573,100		(e)	$	(39,050,748	)

F-30

COROWARE, INC.

Notes to the Consolidated Financial Statements

December 31, 2013 and 2012 (Restated)

NOTE 21 – RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

For the Year Ended December 31, 2012:

Consolidated Statement of Operations	Originally Reported			Restatement Adjustment				As Restated

Revenues	$	1,309,251		$	(33,229	)	(f)	$	1,276,022
Cost of goods sold		846,885			4,500		(f)		851,385
Gross profit		462,366			(37,729	)	(f)		424,637

Operating expenses		780,731			7,624		(g)		788,355

Gain (loss) on derivative valuation		(74,941,525	)		72,343,973		(c)		(2,597,552	)
Interest expense		(623,084	)		(445,423	)	(c)		(1,068,507	)

Net loss before noncontrolling interest		(76,187,986	)		(72,176,998	)	(e)		(4,010,988	)
Net loss		(76,157,284	)		(72,176,998	)	(e)		(3,980,286	)

Net loss per common share	$	(0.49	)	$	0.43		(e)	$	(0.06	)

Notes:

(a)	Reflects restatement due to adjustment to accounts receivable and allowance for doubtful accounts based on substantive testing performed in re-audit of 2012 consolidated financial statements.

(b)	Reflects restatement due to adjustment to accounts payable and accrued liabilities based on substantive testing performed in re-audit of 2012 consolidated financial statements.

(c)	Reflects restatement due to adjustment to notes payable, derivative liabilities and equity accounts based on substantive testing performed in re-audit of 2012 consolidated financial statements.

(d)	Reflects restatement due to adjustment to presentation and valuation of preferred stock based on substantive testing performed during the re-audit of 2012 consolidated financial statements.

(e)	Reflects effects of restatement adjustments that affected 2012 net income.

(f)	Reflects cumulative effect of restatements on items of revenue and cost of goods sold.

(g)	Reflects cumulative effect of restatements on items of general and administrative expenses.

F-31